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1. Burden of Cardiovascular Disease and Adiposity in Pediatric Populations 
1.1 General Overview 
In the United States, 83.6 million adults (≥ 30%) are estimated to have one or more 
types of cardiovascular disease (CVD);1  for both men and women, CVD is the leading 
cause of death in the United States.2 Development of CVD risk factors beings early in 
life, therefore public health efforts have focused attention on CVD risk factor prevention 
in children.3 Recent studies using the National Health and Nutrition Examination Survey 
(NHANES) from 1999-2012 found that pediatric overweight obesity trends had increased 
in the 14 years of follow-up, though may have stabilized between 2009-2010 and 2011-
2012.4,5 More recent evidence has suggested that prevalent overweight and obesity in 
youth continues to rise.6 NHANES data through 2014 indicated that 33% of children 2-18 
years of age were overweight,5,6 and 17% were obese.6 Furthermore, adiposity is known 
to track into adulthood more strongly than other risk factors; most children do not 
outgrow their adiposity status (Figure 1.1).7–11 Steinberger and colleagues reported that 
BMI at 13 years of age correlated strongly with BMI at 22 years of age (r=0.67, 
p=0.0001).11 Collectively, this evidence suggests that the rise in obesity prevalence is 
not a problem isolated to adults, and that CVD risk factor burden in childhood merits 
considerable concern. 
1.2 Influence of Adiposity on Cardiovascular Disease 
Numerous cardiovascular (CV) risk factors influence the progression of CVD in 
adults and children. Results from the Framingham Heart Study suggest, however, that 
adiposity is a foundational risk factor for adult cardiometabolic disturbances.12,13 
Importantly, adult adiposity and the cardiovascular and metabolic consequences have 
origins in childhood.14 Not only is adiposity in childhood predictive of adiposity in 
adulthood,11 but children with overweight and obese parents are more likely to be 
overweight or obese as adults.15 Furthermore, overweight in adolescence has been 
associated with mortality in adulthood; the Harvard Growth Study found a 2.3 times 
higher risk of death from coronary heart disease (95% CI: 1.4-4.1) and 1.8 times higher 
risk of all-cause mortality (95% CI: 1.2-2.7) in adulthood when compared with lean 
counterparts.16,17 Given the prevalence of overweight and obesity in children, 
considerable attention has been paid to the role of adiposity as a precursor to the 
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development of adult CVD.18–20 Identifying children based on adiposity who are at risk for 
clinically evident CVD later in life may be an important strategy for CVD prevention.20,21 
Accordingly, throughout this Introduction substantial emphasis will be given to the 
consequences of overweight and obesity in childhood and adolescence. 
2. Cardiovascular Disease Risk Factors in Pediatric Populations 
2.1 Cardiovascular Disease Risk Factor Overview 
Overweight and obese children and adolescents have a higher prevalence of 
numerous CVD risk factors compared to their normal weight counterparts,18,19,22 
including systolic blood pressure, HDL, and atherogenic lipids.23–27 In addition, childhood 
overweight and obesity are positively associated with insulin resistance28–31 and 
inflammation, including C-reactive protein, inflammatory cytokines, and regulation of 
metabolic gene expression.18,32–36 The longitudinal Bogalusa Heart Study emphasized 
that BMI in children is the best predictor of fasting insulin levels, establishing the 
temporal relationship between BMI and fasting insulin.37 Finally, the Minneapolis 
Childhood Cohort Studies found that adiposity at a mean age of 13 years was correlated 
with adiposity (r=0.67, p=0.0001), insulin resistance (r=-0.5, p=0.006), and LDL 
cholesterol (r=0.48, p=0.01) at a mean age of 22 years.11  
In addition, the Bogalusa Heart Study evaluated CV risk factor clustering; risk 
factors (lipids, insulin, and blood pressure) were measured concurrently with adiposity in 
children. The investigators estimated that 70%, 39%, and 18% of children with a BMI ≥ 
95th percentile had at least 1, 2, or 3 CV risk factors respectively; 65% had an adult BMI 
≥ 35 kg/m2. In the severely obese group, those with a BMI ≥ 99th percentile, 84%, 59%, 
and 33% had at least 1, 2, or 3 CV risk factors; 88% had an adult BMI of ≥ 35 kg/m  
(Figure 1).2,9,38 Further evidence supports clustering of CV risk factors, often labeled 
metabolic syndrome, with increasing adiposity.14,19,39–41 Data from NHANES III suggests 
28.7%, 6.8%, and 0.1% of adolescents with a BMI ≥ 95th, ≥85th to <95th, and <85th 
percentiles respectively had prevalent metabolic syndrome.14 These CV risk factor 
clusters have been shown to track into adulthood,42 and increase future risk of CVD in 
adolescence43–46 and adulthood.47–51 Given the evidence supporting increased CV risk 
factor levels with childhood overweight and obesity, the concurrent secular trends of 
prevalent overweight, obesity, and severe obesity suggest a worsening of CVD risk 
profiles in pediatrics.  
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2.2 Cardiovascular Risk Factor Tracking 
In addition to the increased burden of risk factors with overweight and obesity, both 
weight and CV risk factor status have been shown to track from childhood into 
adulthood. As mentioned above, childhood adiposity, in particular, has repeatedly been 
shown to be a predictor of BMI in adulthood.8,9,11,17,52 The Bogalusa Heart Study found 
that children (mean age 11.4 years) with a BMI ≥ 99th percentile, 88% and 65% had an 
adult BMI ≥ 35 kg/m2 and ≥ 40 kg/m2 respectively.9 According to a recent NHANES 
analysis in 12-21 year old adolescents, obese adolescents were substantially more likely 
to develop severe obesity in adulthood compared to overweight or normal weight 
adolescents (HR: 16.0, 95% CI: 12.4-20.5).10 These studies also reinforce that adiposity 
in childhood is independently predictive of insulin resistance, dyslipidemia.8,11 Finally, 
results from the Cardiovascular Risk in Young Finns Study over 27 years of follow-up 
found that BMI (r=0.43-0.46), systolic blood pressure (r=0.27-0.32), total serum 
cholesterol (r=0.50-0.52), LDL (r=0.52-0.56), HDL (r=0.46-0.51), and triglycerides 
(r=0.27-0.30) tracked from childhood to adulthood (all p<0.0001). In the same study, all 
subjects with high childhood risk factor levels had elevated odds of having abnormal 
CVD risk factors in adulthood; children and adolescents who were overweight or obese 
had a 5.7 (95% CI: 3.6-9.1) and 13.6 (95% CI: 8.3-22.3) higher odds of overweight or 
obesity in adulthood.53 
2.3 Cardiovascular Disease Risk Factor Morbidity and Mortality 
Cardiovascular risk factors in childhood are associated with adiposity, track over 
time, and have a tendency to cluster. Furthermore, these same CVD risk factors have 
been shown to be associated with subclinical vascular changes and CVD morbidity and 
mortality in adulthood. 
2.3.1 Childhood Cardiovascular Risk Factors & Subclinical Atherosclerosis 
Emphasis has been placed on subclinical atherosclerosis as it represents an 
intermediate step in the pathophysiology from the presence of CV risk factors to frank 
CVD. Broadly, subclinical atherosclerosis is defined as vascular damage that has yet to 
manifest into clinical signs or symptoms.54–56 A number of landmark pediatric cohort 
studies have evaluated the impact of childhood risk factors and development of 
subclinical atherosclerosis.  
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In the Bogalusa Heart Study, Li et al. found that a 1 standard deviation difference in 
childhood LDL cholesterol (OR: 1.42, 95% CI: 1.14-1.78) and BMI (OR: 1.25, 95% CI: 
1.10-1.54) were predictive of carotid intima media-thickness (upper quartile) in 
adulthood.57 Evidence from the Muscatine and Young Finns studies found similar 
results, emphasizing the impact of childhood risk factor burden and future subclinical 
CVD.7,58,59 In the Young Finns study, elevated adolescent (12-18 years) serum LDL, 
systolic blood pressure, BMI, and smoking were positively associated with increased 
carotid intima-media thickness (cIMT) in adulthood. When the investigators evaluated 
absolute number of risk factors in childhood (3-8 years), they found a weak, though 
statistically significant, relationship with increased cIMT in adulthood for men but not 
women. Concurrently, in youth (9-18 years) the absolute number of risk factors was 
positively associated with elevated cIMT.60 In a separate analysis in the Young Finns 
cohort, childhood risk factors were positively associated with reduced arterial elasticity, 
but the effect was attenuated substantially when adjusting for risk factor levels in 
adulthood; systolic blood pressure was the only borderline significant risk factor for 
reduced arterial elasticity after adjusting for risk factors in adulthood (p=0.06).61 
Collectively, these studies provide strong evidence that risk factor burden in childhood 
has physiological CV implications in adulthood. 
2.3.2 Childhood Cardiovascular Risk Factors & Atherosclerosis 
Atherosclerosis, the underlying cause of coronary heart disease, is the leading 
cause of cardiovascular death in North America.3 Atherosclerosis is well studied in adults 
but has been shown to be present in the young dating back to autopsies done on 
soldiers from the Korean War.62 Broadly speaking, atherosclerosis begins with vascular 
fatty streaks, progresses to fibrous plaques, raised lesions (secondary to lipid deposition, 
smooth muscle and connective tissue proliferation), and culminates with lesion rupture 
(thrombosis), acute ischemia, or vascular rupture. Major clinical manifestations of 
atherosclerosis such as myocardial infarction and stroke occur in middle or late 
adulthood and are predominant public health concerns in their own right.3,63,64 
More recent autopsy studies in childhood have confirmed that the atherogenic 
process begins in childhood.43–46 The Pathological Determinants of Atherosclerosis in 
Youth (PDAY) study,65 a multi-center study on black and white participants performed 
autopsies on 2876 subjects between 15 and 34 years of age who died of external 
causes from 1987-1994. The PDAY study reported that carotid intimal atherosclerotic 
5  
lesions were present in all of the aortas and over half of the right coronary arteries in the 
youngest participants (15-19 years of age). Prevalence and severity of atherosclerotic 
lesions in both locations increased with age. Furthermore, for every 30 mg/dL increase 
in non-HDL cholesterol, a visible increase in burden and severity of atherosclerosis was 
found; lack of risk factor burden was associated with the absence of atherosclerotic 
lesions.66 The Bogalusa Heart Study, a multi-racial cohort, found that grouped CV risk 
factors measured in children and young adults were correlated (r=0.70, p<0.001) with 
the burden of lesions in the coronary arteries and the aorta; 19.1%, 30.3%, 37.9% and 
35.0% of subjects with 1, 2, 3, and 4 risk factors had aortic fatty streaks (p test for 
trend=0.003).43 To date, only two studies have examined the relation between CV risk 
factors in youth and vascular health outcomes in young adulthood; although informative, 
one was limited to a unique minority population67 and the other had a small sample 
size.68 Therefore, it is clear that risk factor burden in childhood is associated with 
initiation and progression of atherosclerotic development. 
2.3.3 Childhood Cardiovascular Risk Factors & Clinical Cardiovascular Disease 
Until recently, there were no prospective long-term studies evaluating the impact of 
childhood risk factor development and frank CV events in adulthood. Notably, a recent 
longitudinal study in Israel reported that cardiovascular mortality in adulthood was 3.5 
times higher (95% CI: 2.9-4.1) and diabetes-related mortality was 17.2 times higher 
(95% CI: 11.9, 24.8) for individuals classified as having obesity as adolescents.69,70 
Furthermore, in adolescents with hypertension, incident stroke was 3.1 times higher 
(95% CI: 1.76, 5.54) than normotensive adolescents.71 Nonetheless, it is important to 
consider how CV risk factors manifest into subclinical cardiovascular disease, an 
intermediate and modifiable stage in the development towards life threatening CVD 
outcomes. Compelling evidence can been found by looking at genetic disorders that 
accelerate the pathogenesis of CVD. Homozygous hypercholesterolemia, a condition 
that causes extremely high levels of LDL cholesterol levels starting in infancy (above 800 
mg/dL), results in CVD events in the first decade of life and a reduced life expectancy. 
As would be expected, heterozygous hypercholesterolemia (generally LDL levels >200 
mg/dL) results in a less extreme cardiovascular profile, nonetheless 25% of women and 
50% of men have hard coronary events by 50 years of age.3 In natural history studies of 
Type II diabetes mellitus (DMII), heart disease and stroke are the leading causes of 
death in DMII; adults diagnosed with DMII are 2 to 4 times more likely to have CVD or 
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stroke than non-diabetics.1 Furthermore, in the PDAY study hyperglycemia was 
associated with advanced atherosclerosis of the coronary arteries.44–46 Finally, in the 
Princeton Lipid Research Clinics Follow-up Study, metabolic syndrome (MetS) predicted 
CVD in adults after 25 years of follow-up (OR: 14.6, 95% CI: 4.8-45.3, p<0.0001).72 
Together, these data support the belief that risk factors in childhood impact clinical CVD 
events in adulthood. 
2.3.4 Mortality & Life Expectancy 
Numerous studies have shown the negative impact of overweight and obesity in 
childhood and adolescence with long-term morbidity and mortality.73–76 in a cohort of 
Danish children 7 to 13 years of age, those with a higher BMI had an increased risk CHD 
morbidity and mortality in adulthood. The risk of a fatal or non-fatal CHD event increased 
linearly with age, and across the entire BMI distribution.77 Franks et al. found that 
obesity, hypertension, and glucose intolerance in childhood (mean age of 11) were all 
positively associated with premature death. The death rates were more than double in 
children with the highest quartile of BMI compared to the lowest quartile (RR: 2.3, 95% 
CI: 1.46, 3.62), and 57% higher in children with hypertension (RR: 1.57, 95% CI: 1.10-
2.24).78 While CVD mortality rates continue to decline,1 the increasing rates of life 
expectancy in the United States are attenuating.79 Olshansky et al. argues that current 
life expectancy estimates may decrease by 2030 due to the impact of obesity on 
longevity.80 
3. Reversibility of Cardiovascular Disease Risk Factors in Pediatric Populations 
From a clinical perspective, it is fundamental to determine whether the associations 
between childhood risk factors and adult outcomes are due simply to tracking (i.e. 
childhood adiposity tracks to adulthood), or whether circumstances in childhood have 
permanent impacts independent of adult risk factor status. Current evidence suggests 
that many of the common CV risk factors present in childhood (LDL cholesterol, smoking 
status, and blood pressure) are associated with subclinical atherosclerosis independent 
of adult risk factor levels. Furthermore, clustering of CV risk factors in adolescence (i.e. 
having 1, 2, 3 or 4 CV risk factors) was associated with subclinical disease in stratified 
analyses in adults with different numbers of these same risk factors.58,81 Interestingly, 
childhood adiposity status may be reversible. Overweight or obese children who 
maintained or increased their adiposity status as adults had increased cardiometabolic 
risks whereas the risks were absent in individuals who were normal weight as adults. 
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Despite this favorable outcome, 65% of overweight or obese children became obese as 
adults.20 Therefore, multiple CV risk factors in childhood appear to have independent 
impacts on subclinical disease, and adiposity status though reversible is unlikely to occur 
in clinical practice. 
4. Severe Obesity in Pediatric Populations 
Though childhood obesity prevalence may be plateauing,4,5 some evidence suggests 
it continues to rise.6  Nonetheless, severe obesity appears to be the most rapidly rising 
category of adiposity.6 Current NHANES and California Health Plan prevalence statistics 
estimate that between 4% and 6% of children are severely obese, with the highest 
prevalence of 11.9% in African American girls.82–84 The American Heart Association 
(AHA) released a Scientific Statement dedicated to severe obesity in childhood, with 
clinical implications on the identification, associated health risks, and treatment options. 
The writing group defined severe obesity in childhood (≥2-18 years of age) as having a 
“BMI ≥120% of the 95th percentile or absolute BMI ≥35 kg/m2, whichever is lower based 
on age and sex.82,84  
These same nationally representative data suggest alarming trends for severe 
obesity: class 2 obesity has increased from 3.8% to 5.9% (p=0.04), and class 3 obesity 
has increased from 0.9% to 2.1% (p=0.002).84,85 Childhood overweight and obesity 
increase CV risk in adulthood; severe obesity shows much stronger associations in the 
magnitude and severity of CV risk later in life. As mentioned previously, obesity in 
adolescence has been shown to be positively associated with obesity and severe 
obesity in adulthood; prevalence estimates project severe obesity will increase by 130% 
by 2030.10 Furthermore, based on Behavioral Risk Factor Surveillance system data 
(BRFSS), obesity and severe obesity in adulthood are predicted to increase steadily 
through 2030. Finkelstein et al. estimate a 33% and 130% increase in the prevalence of 
obesity and severe obesity respectively; medical savings based on prevalence estimates 
remaining at 2010 levels suggest medical cost savings of $549.5 billion.86 Furthermore, 
in the National Longitudinal Study of Adolescent Health cohort, obese adolescents had 
significantly higher risk of severe obesity (HR: 16.0, 95% CI: 12.4-20.5) in adulthood 
than normal or overweight adolescents after adjusting for race/ethnicity, age, and 
weighted for national representation.10 Therefore, not only do researchers and clinicians 
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need to consider the intermediate implications of overweight and obesity in childhood. 
Attention to severe obesity and subclinical and overt atherosclerosis is compulsory. 
5. Ideal Cardiovascular Health & American Heart Association 2020 Goals 
In 2010, the American Heart Association (AHA) established strategic Impact Goals 
for 2020: “By 2020, to improve the cardiovascular health of all Americans by 20%, while 
reducing deaths from CVDs and stroke by 20%.”87 Seven health metrics have been 
established to define CV health – categorized as poor, intermediate, and ideal. Ideal CV 
health is defined as meeting all seven CV health metrics and the absence of CV disease 
or CV medication use. The seven cardiovascular health metrics are split into 4 health 
behaviors (smoking status, physical activity, dietary patterns, and BMI) and 3 health 
factors (optimal fasting total cholesterol, blood glucose, and blood pressure). Table 1.1 
details specific definitions of poor, intermediate, and ideal CV health for children aged 
12-19 years. Overall levels of ideal CV health are abysmally low; approximately 0.1% of 
American adults88,89 and less than 1% of American children meet all 7 ideal CV health 
metrics.90 Less than 50% of adolescents meet ≥5 of the 7 ideal CV health metrics.91 
According to these AHA metrics, children aged 12-19 years are generally in better CV 
health than adults in the United States. However, children fare modestly worse for 
physical activity (63.5% have poor or intermediate physical activity vs. 59.1% in adults) 
and dietary intake (99.9% have poor or intermediate dietary intake vs. 99.5% in adults). 
Prevalence trends from 2007-2008 to 2009-2010 indicate that ideal dietary patterns have 
decreased.1 The low prevalence of meeting ideal dietary and physical activity will likely 
exacerbate the worsening outlook of obesity in childhood, adolescence and 
adulthood.90,91  
Importantly, the number of ideal CV health metrics in childhood is positively 
associated with a lower risk of various CV outcomes in adulthood. A recent study in the 
Cardiovascular Risk in Young Finns prospective cohort study, children in ideal CV health 
had lower odds of: 1) hypertension (OR: 0.66, 95% CI: 0.52-0.85), 2) metabolic 
syndrome (OR: 0.66, 95% CI: 0.52-0.77), 3) elevated low-density lipoprotein cholesterol 
levels (OR: 0.66, 95% CI: 0.52-0.85), and 4) increased cIMT thickness (OR: 0.75, 95% 
CI: 0.60-0.94).90,92 Prioritizing population-level ideal cardiovascular behaviors and 
metrics in childhood is paramount for public health efforts aimed at CVD prevention. 
6. Relevance of Subclinical Cardiovascular Disease in Pediatric Populations 
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As previously discussed, CVD is a lifelong process with origins in childhood. Clinical 
CVD events or complications, however, arise many decades later in life.43 Although 
diagnosis, management, and treatment of CVD has been evolving, the development of 
frank CVD is rarely seen in childhood.93 Therefore, surrogate biomarkers or 
measurements of subclinical disease merit substantial consideration for primary CVD 
prevention in children and adolescents. Risk assessment measures to predict 
development of CVD have been developed, most notably the Framingham Risk Score 
from the Framingham Heart Study.94,95 The need for the development of similar tools in a 
pediatric population is apparent, as the prevalence of overweight, obesity, and severe 
obesity has been increasing in recent decades.  
Subclinical atherosclerosis offers a window of opportunity to recognize early CV 
pathophysiological processes. Classic clinical manifestations of CVD such as stroke and 
myocardial infarction are known to be a result of underlying atherosclerosis and 
disrupted vascular integrity, and adults with no CV risk factors and healthy CV behaviors 
have low rates of CVD.96–99 Furthermore, evidence suggests that CV risk factors present 
in childhood independently predict subclinical atherosclerosis in adulthood.57–59 
Considering subclinical CVD in a pediatric population is relevant to CVD prevention 
longer term, but also to the timing of development of subclinical atherosclerosis. Timing 
of atherosclerosis occurrence is critical, particularly as it relates to when an intervention 
should occur and what type of intervention is most appropriate. 
7. Pathophysiology of Subclinical Cardiovascular Disease 
7.1 Vascular Structure & Function 
The vascular system, composed broadly of arteries and veins, circulates 
continuously throughout the body. The structure and function of blood vessels, however, 
changes based on location. Interestingly, a consistent structural component of the 
vascular system is the endothelial cell; these cells comprise the single-celled innermost 
layer of all blood vessels, the endothelium.100,101 For example, capillaries are comprised 
of only the endothelium, whereas larger arteries and veins include additional connective 
tissue and/or smooth muscle components.101 The endothelium acts as a semipermeable 
barrier between the bloodstream and blood vessel, but also serves various functional 
roles: regulation of blood flow, vascular repair, and vascular tone.102,103 One primary 
function of the endothelium involves nitric oxide secretion, which acts as a 
vasodilator.104–106 Nitric oxide is known to be protective of vasculature, and has also 
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been established to have numerous anti-atherogenic properties: inhibition of leukocyte 
adhesion,107 platelet aggregation,108 and smooth muscle proliferation.109 
Dysfunction of the endothelium within the arterial system is thought to be one of, if 
not the initial step, in the pathogenesis of atherosclerosis.110 Endothelial and smooth 
muscle damage are generally initiated by classic CV risk factors, catalyzing the 
inflammatory and proliferative immune response indicative of vascular injury. This 
process takes decades to accumulate, and evaluation of subclinical atherosclerosis 
represents a possibility to measure and track the atherosclerotic process. Because 
atherosclerosis disrupts both the function and structure of the arterial system, numerous 
invasive and non-invasive imagine techniques have been developed to measure 
subclinical vascular disease burden.  
7.2 Atherosclerosis & Subclinical Atherosclerosis 
Subclinical atherosclerosis is most commonly identified as a systemic 
pathophysiological process affecting the entire vascular system, and plays a pivotal role 
in the etiology of coronary artery disease and other CVDs.100,102 Atherosclerosis is a 
progressive disease involving the accumulation of fatty streaks, inflammation, infiltration 
of various immune cells, and development of scar tissue within the vessels. As a leading 
cause of coronary artery disease and CVD mortality, classic CVD risk factors and 
genetic predisposition contribute to atheromas in addition to a thickening and loss of 
elasticity of the arterial wall.111 Atherosclerosis is often categorized as a subclinical 
disease because it is rarely diagnosed in absence of other cardiovascular events (i.e. 
heart attack or stroke). Atherosclerosis generally occurs in various types and sizes of 
arteries (primarily in the heart, brain, kidneys, and extremities), though is known to be 
present in some specific anatomical locations: the carotid arteries and bulb, and 
coronaries arteries.112 
Atherosclerosis is a disease that disrupts both the function and structure of 
circulatory system,100,113 and is a systemic process of the arterial system that involves 
chronic vascular inflammation, and accrual of lipids and immune cells within the arterial 
walls. It has been established that atherosclerosis is initiated by a synergistic 
accumulation of CVD risk factors that cause immediate injury to the endothelium and 
smooth muscle, thereby initiating an inflammatory process that catalyzes a thickening of 
the endothelium. With thickening, the vessel walls increase thereby decreasing the size 
of the vessel lumen (arterial diameter) and a reduction in blood flowing through the 
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artery. Although atherosclerosis may take decades to develop formally, it is commonly 
accepted that the initial processes take place earlier in life and develops over time.1  
7.2 Measuring Subclinical Atherosclerosis 
Two imagining techniques are most commonly cited for quantification of subclinical 
atherosclerotic disease burden: computed tomography (CT) for evaluation of coronary 
artery calcification (CAC) and B-mode ultrasound for evaluation of carotid artery intima-
media thickness (cIMT). Early identification of subclinical atherosclerosis through 
diagnostic imaging is commonly utilized in clinical and research settings, though some 
evidence suggests limited utility in certain populations. High-resolution ultrasound 
measuring cIMT is the most commonly used technique to evaluate arterial structure 
because it: (i) does not expose subjects to radiation, (ii) is more appropriate for a low risk 
population whereas CAC is recommended for those at intermediate risk of heart disease 
(i.e. an estimated 10-year risk of 10-20%), and (iii) measurement variability with CAC 
can be problematic.114 The common carotid artery is the anatomical site most frequently 
measured with high-resolution ultrasound because it is linked to CV risk factors,115 
subclinical atherosclerosis,116 adverse cardiovascular events,117,118 and it incurs minimal 
measurement error.55  
7.3 Factors Impacting Subclinical Atherosclerosis 
The primary factors impacting cIMT are: (i) aging, (ii) sex, (iii) adiposity, (iv) physical 
activity, and (v) smoking status.55,100  
7.3.1 Age 
As has been discussed, atherosclerosis develops over an extended period of time. 
Therefore, it is not surprising that evidence shows an increase in cIMT with aging.119–121 
It should be noted, however, that as cIMT is impacted by both adiposity and physical 
activity it remain unclear whether the increase in cIMT with time is due to aging directly 
or changes in lifestyle behaviors.  
7.3.2 Sex 
In general, men have higher cIMT values (in millimeters) than women.122 It remains 
to be determined whether the sex difference in cIMT is driven by differences in CVD risk 
factors by sex, or by sex alone. Generally speaking, most differences in arterial function 
are attenuated when analyses adjust for baseline brachial artery diameter, evidence in 
regard to vascular structure (cIMT) is sparse.123,124 Importantly, the impact of sex on 
cIMT has not been reported in children or adolescents (<18 years of age).125 
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7.3.3 Adiposity 
Repeatedly, adult cIMT has been shown to be higher in individuals that are 
overweight or obese in comparison to their lean counterparts. These results hold even 
after adjusting for current levels of classic CVD risk factors.126,127 Furthermore, obesity 
has also been shown to be inversely associated with endothelial function in adult 
populations.128,129 In children, a positive association between obese and overweight and 
arterial structure (cIMT) has been reported,130,131 whereas an inverse association 
between weight and arterial function has been identified.132–134 the consistent evidence 
that both arterial structure and function are affected by adiposity provides reasonable 
evidence to suggest that improvements in vascular health could be achieved with weight 
loss interventions. One clinical trial, for example, found that a 1-year weight loss 
intervention reduced cIMT in children.135 Results in adults have been similar but variable 
in magnitude, likely due to the population studied, amount of weight loss, and 
mechanisms of weight loss.136  
7.3.4 Physical Inactivity 
Cross-sectional studies examining leisure time physical activity and TV watching 
have suggested that no association exists between level of physical inactivity and 
cIMT.137,138 Longitudinal studies have been mixed139,140 and clinical trials have generally 
found no effect on exercise training and cIMT in adults.138,141 Interestingly, in a pediatric 
population, the results are more conclusive; one clinical trial evaluating a 6-month 
aerobic exercise intervention demonstrated an improvement in both arterial structure 
and function in obese children.131 Another study found improvement of endothelial 
function in an 8-week exercise intervention of overweight children and adolescents.142 It 
is possible that chronological age impacts whether physical activity is able to alter 
arterial structure and function. Again, this information lends itself to a greater emphasis 
on public health efforts and interventions early in life. 
7.3.5 Smoking Status 
Smoking is a well-established risk factor for CVD, so it comes as no surprise that 
smoking has negative effects on vascular structure and function.143 Numerous cross-
sectional and longitudinal studies have identified that smoking is positively associated 
with an increased cIMT143,144 and lower vascular function.145–147 Importantly, inhalation of 
passive smoke is also damaging to both arterial structure and function. In one study, 
dose-response relationship was found between exposure to second-hand smoke and 
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cIMT thickening.146 Furthermore, EDD was found to be lower in both individuals exposed 
to second hand smoke currently and formerly compared to nonsmokers. It is unclear 
how permanent the effect of active or passive smoking are on vascular health.148 
8. Subclinical Cardiovascular Disease in Pediatric Populations: Gaps & Future 
Implications 
As summarized above, current pediatric prospective cohort studies such at Young 
Finns, Bogalusa, and Muscatine offer considerable evidence regarding the associations 
of risk factors in childhood and development of subclinical atherosclerosis and CVD in 
middle adulthood. Precise and reliable measurement of subclinical atherosclerosis in 
childhood in conjunction with longer term follow-up provides an excellent opportunity to 
predict future risk of: (i) CV outcomes such as myocardial infarction and stroke later in 
life, and (ii) subclinical disease itself.  
Subclinical disease measurement could potentially help improve risk stratification 
and prediction in a pediatric population, where frank CV events rarely occur. 
Furthermore, the ability to categorize children and adolescents according to their future 
risk of subclinical disease could provide: (i) improvement in our understanding of when 
risk factor burden has the biggest impact on vascular health (i.e. childhood, pre-
adolescence, adolescence, etc.), (ii) information for development of risk prediction of 
subclinical or early CVD, and (iii) help target appropriate timing of interventions and 
treatments (i.e. providing treatments or interventions earlier in the disease process or 
when behavioral change may be more malleable). Continued efforts to treat and prevent 
primary or secondary cardiovascular events is of paramount importance. 
Simultaneously, a more targeted consideration and evaluation of subclinical disease in 
youth and young adulthood is warranted, particularly considering the increased 
prevalence of overweight, obesity, and severe obesity in pediatric populations. 
In conclusion, excess adiposity remains a serious public health threat in childhood 
and adolescence; obesity in adolescence is associated with increased CVD morbidity 
and mortality later in life. Subclinical atherosclerosis is a critical factor for future 
development of overt CVD, and thus warrants attention for CVD prevention in earlier 
periods of life.  Little is known about subclinical atherosclerosis in early adulthood; this 
dissertation aims to address this gap in two ways.  First, by developing a model that 
uses risk factors in childhood and adolescence to predict subclinical atherosclerosis in 
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middle adulthood, and second by examining the association between CVD risk factors in 
adolescence and subclinical atherosclerosis in early adulthood.  Lastly, in an effort to 
prioritize CVD prevention, the American Heart Association developed the ICH metric as 
a tool to promote cardiovascular health and reduce future CVD.  No data exist on the 
prevalence of ICH across levels of adiposity, particularly severe obesity, in a pediatric 
population.  Thus, the final aim of this dissertation was to examine the distribution of ICH 
metrics by adiposity status. 
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Table 1.1. Definitions of poor, intermediate, and ideal cardiovascular health 
according to AHA 2020 goals: health behaviors and risk factors for children 12-19 
years of age. 
Metric Poor Intermediate Ideal 
Smoking status Tried > 30 d ago … Never tried; never smoked whole cigarette 
BMI >95th percentile 85th- 95th percentile <85th percentile 
Physical activity 
level None 
>0 and <60 min moderate 
or vigorous activity every 
day 
≥60 min moderate or 
vigorous activity every 
day 
Healthy Diet Score* 0-1 components 2-3 components 4-5 components 
Total Cholesterol ≥200 mg/dL ≥170 - <200 mg/dL <170 mg/dL 
Blood Pressure >95th percentile 90-95th percentile <90th percentile 
Fasting Blood 
Glucose ≥126 mg/dL 100 - 125 mg/dL <100 mg/dL 
BMI indicates body mass index. 
*The Healthy Diet Score is based on adherence to the following dietary recommendations: fruits and 
vegetables, ≥4.5 cups per day; fish, 2 or more 3.5-oz servings per week; sodium, <1500 mg/d; sugar-
sweetened beverages, ≤450 kcal (36 oz) per week; and whole grains, ≥3 servings a day scaled to a 2000-
kcal/d diet. Reprinted with permission Circulation. 2016;134: e236-e255 
© American Heart Association, Inc. 
 
Figure 1.1. The relation of BMI-for-age and the proportion of children with ≥1, ≥2, 





Paper 1: Risk Prediction and Vascular Health 
Introduction 
Atherosclerosis begins in childhood, and is a critical component to the future 
development of cardiovascular disease (CVD).1,149 Evidence of advanced coronary 
atherosclerosis in young adults has been accumulating since autopsy studies performed 
on Korean and Vietnam War casualties.62  Using additional autopsy evidence, the 
Pathological Determinants of Atherosclerosis in Youth (PDAY) Study reinforced these 
findings in the second half of the 20th century.66  The PDAY investigators estimated that 
5% of men 25-29 years of age and 20% of men 30-34 years of age had advanced 
coronary artery atherosclerotic lesions (≥40% stenosis).  Established adult CVD risk 
factors for coronary heart disease such as adiposity, dyslipidemia, hyperglycemia, and 
smoking status were found to be cross-sectionally associated with prevalence and 
severity of atherosclerosis in the PDAY cohort.44–46  Subclinical cardiovascular outcomes 
such as carotid intima-media thickness (cIMT) have become widely accepted as relevant 
to earlier stages of CVD.55  Identical CVD risk factors have been studied in numerous 
pediatric longitudinal cohort studies, and consistently are associated with subclinical 
atherosclerosis in middle adulthood (mid-30’s).57–59   
Based on post-mortem evidence of atherosclerotic development early in life, the 
PDAY investigators proposed a cross-sectional risk score using CVD risk factors to 
predict coronary atherosclerosis in early adulthood (all assessments: 15-34 years).150 
This risk score closely resembles the Framingham Risk Score for coronary heart disease 
prediction.12,151  Though innovative, this risk prediction score has a number of limitations.  
First, it used post-mortem, cross-sectional data on individuals who died accidentally.  
Post-mortem evaluation provided concrete evidence of atherosclerosis, but required 
unconventional methods for risk factor measurement.  For example, presence of 
hypertension was determined based on renal artery intimal thickness demonstrating an 
average blood pressure of ≥ 110 mm Hg.152  In contrast, in a living study population, 
brachial artery blood pressure would generally be assessed using a clinical grade blood 
pressure device or mercury sphygmomanometer.153  Finally, cross-sectional data may 
not lend themselves to future risk prediction.  Importantly, predicting future risk could 
help identify individuals who could benefit from interventions thereby preventing future 
development of disease.  Furthermore, the age range of participants in PDAY (15-34 
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years) included only a small portion of adolescence and focused more heavily in young 
adulthood.12,151   
Although the association between childhood risk factors and increased cIMT in 
middle adulthood (mid-30’s) has been established,58,154,155 the application of this 
information in a risk prediction model has yet to be achieved using longitudinal data in a 
pediatric population.  Risk prediction models quantify the impact of numerous risk factors 
(both innate and modifiable) on the development of various diseases. In general, 
pediatric risk prediction models have focused on common clinical ailments such as 
asthma156 and fever management.157  Previously considered diseases of adulthood, 
prediabetes158,159, type 2 diabetes160,161, dyslipidemia25,162,163, and  hypertension164,165 
have been increasing in adolescence, primarily in parallel with the obesity 
epidemic.166,167 Thus, risk prediction models for subclinical atherosclerosis in early 
adulthood may be more relevant than when these diseases were less prevalent.  To the 
best of our knowledge, no studies to date have developed a model predicting subclinical 
atherosclerosis at any stage in life.  Thus, the objective of this study was to develop a 
risk prediction model that predicted cIMT in middle adulthood using relevant 




 The Prevention of High Blood Pressure in Children (PHBPC) study is a longitudinal 
cohort study initiated at the onset of the 1977-78 school year in Minneapolis Public 
Schools; the sampling and measurements have been previously described.168,169 Basic 
anthropometric data were collected twice annually until high school, and annually 
through the end of high school. Three post-high school visits occurred: (i) visit 2 (1989-
91), (ii) visit 3 (1991-95), and (iii) visit 4 (2007-11).170 The cohort was randomly selected 
from all incoming students in 1st through 3rd grades that participated in a school-wide 
blood pressure (BP) screening program (n=2641). In an effort to enroll children with a 
higher future CV risk, a cohort was selected that included: (i) all children at the upper 
and lower 5th percentiles of the normal systolic BP distribution, (ii) 50% of the African 
American children that remained, and (iii) 10% of the white children that remained.  At 
each post-high school study visit, participants underwent extensive clinical examinations; 
cIMT was assessed at visit 4.  For the current analysis, we used visit 3 as baseline 
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(mean age: 23 years) and visit 4 as follow-up (mean age: 38 years). The University of 
Minnesota Institutional Review Board approved this study and all exams were conducted 
with written informed consent (from parents when children were below 18 years old, with 
verbal assent from the children; from the participants themselves after they came of 
age).  
Cardiovascular Disease Risk Factor Assessment 
Subsequent to arriving at the Masonic Clinical Research Unit (MCRU) at the 
University of Minnesota, all participants provided written informed consent.  All 
participants were also examined according to a standardized protocol developed by 
study investigators and approved by the University of Minnesota Institutional Review 
Board.  Relevant predictors were determined through an extensive literature review and 
availability in the PHBPC cohort.  Protocols for data collection were similar across visits 
unless otherwise noted. 
Anthropometrics & Blood Pressure 
Two seated systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
measurements were taken in the right arm using a random zero sphygmomanometer; an 
average of these two measurements were used for all analyses.  Weight was measured 
using a medical grade balance scale without shoes; height was measured using a 
standing stadiometer to the nearest centimeter.  BMI was calculated as weight 
(kilograms; kg) divided by height (meters; m) squared.  BMI calculations and height 
measurements were transformed into age- and sex-specific percentiles based on 
Centers for Disease Control and Prevention guidelines.171  
Sociodemographics 
Age, race, and sex were collected at all visits according to standardized research 
questions.  Age was asked to the nearest year, race was categorized by the following: 
white, black, Native American, Asian, Hispanic, or other.  Sex was assessed as male or 
female. 
Carotid Intima-media (cIMT) Assessment 
All vascular health assessments were performed in a quiet room at a comfortable 
temperature (22-23°C) at the final study visit (mean age: 38 years).  Participants were 
asked to refrain from caffeine and medication consumption prior to their scheduled clinic 
visit.  After lying in a supine position for 15 minutes, a standard high-frequency 
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ultrasound device (Image Point HX, Philips Medical) using a 7.5 MHz linear array probe 
was used to capture B-mode images of the common carotid artery (carotid intima-media 
thickness; cIMT).  The transducer was held at a constant distance from the skin, and 
over a fixed point on the carotid artery using a stereotactic arm.  All images were 
recorded, saved, imported, and stored on a separate computer system for storage and 
future analysis.   
Appropriate software for high-frequency ultrasound imaging of vasculature (CVI 
Analysis, Information Integrity, Boston, MA) was used for measuring resting longitudinal 
images of the common carotid artery (1-2 cm proximal to the carotid bulb).  Images were 
recorded directly onto the hard drive of a PC computer with the aforementioned 
software.  Arterial images and measurements (arterial lumen diameter, intima-media 
thickness, and distensibility) were collected at 30 Hz for the first 475 ms of the cardiac 
cycle to acquire both the maximal and minimal lumen diameters (media-adventitia 
border of the near wall to the intima-lumen surface of the far wall).  From preliminary 
data, within person analyses estimated a mean difference (± SD) of 0.02 ± 0.03%.100,113 
Higher cIMT indicates lower vascular health (i.e. lower cIMT is better). 
Exclusions and Missing Data 
Of the 2641 children randomly selected to participate in the cohort, 1207 met 
inclusion criteria and provided written informed consent for participation using University 
of Minnesota Institutional Review Board approved documents.  These 1207 children 
were examined twice yearly until high school; at which time they were examined 
annually.  A post-high school examination was conducted on average 2 years after 
graduation (mean age of 19 years); at this exam 817 individuals participated.  There 
were no baseline characteristics that differed between the 817 individuals who 
participated and the 319 individuals lost to follow-up.  At the most recent clinic visit 
conducted in 2007-11, when participants were on average 38 years of age, a more 
complete cardiovascular profile and cIMT was collected on 444 participants; our final 
sample size was 444 observations. 
Statistical Analysis 
Descriptive statistics are presented as mean ± standard deviation (SD) or as a 
frequency distribution (%) by cIMT quartile.  Of the 444 participants at the most recent 
clinic visit, we did not exclude any individuals because all 444 participants had at least 
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one previous clinic visit with a complete risk factor profile.  Participants were measured 
multiple times throughout the study period, thus general estimating equations (GEE) 
regression models were used to estimate differences in cIMT in models including known 
CVD risk factors.172  This modeling approach can be used in contexts with repeated 
exposure measurements on the same individual at different time points (i.e. multiple 
informants).173  GEE model specifications included an independent working correlation 
matrix, a robust standard error variance estimator, a Gaussian distribution, and a 
canonical identity link.  This analytic approach requires meeting the assumption that any 
missing data are missing completely at random (MCAR); no missing data were present 
in our current data based on our criteria of: 1) presence of valid data on the outcome of 
interest (cIMT), and 2) at least one clinic visit prior to the final visit with complete risk 
factor assessment. 
Our candidate variable list was limited to the following demographic and 
anthropometric variables: age, race, sex, BMI percentile, height percentile, SBP, and 
DBP.  To improve ease of interpretation, all variables were modeled using a one-unit 
difference with the exception of percentile variables (BMI and height) and blood pressure 
variables (SBP and DBP) which were converted to a 10 percentile and 10 mm Hg unit 
difference, respectively.  We did not perform a formal candidate variable selection 
process because all aforementioned variables were reasonable to include based on 
literature review of CVD risk factors, and were consistently associated with cIMT in 
middle adulthood.58,59,174 To determine our final risk prediction model, we fit three GEE 
models: 1) Model 1 adjusted for baseline age, sex, race, BMI percentile, SBP and DBP, 
and 2) Model 2 additionally adjusted for height percentile.  We considered a third model 
to account for potential interactions and non-linear associations.  Interactions were 
initially tested for all variables in a stepwise fashion; results were highly dependent on 
the order in which variables were added to the model.175  Thus, we chose to model 
interactions that included BMI percentiles or SBP, which would be expected based on 
current literature.176–178  Interaction terms were included in our final model if they were 
statistically significant using the traditional cutoff of p<0.05.  Thus, Model 3 additionally 
adjusted for cubic and quadratic terms for SBP and two-way interaction terms that 
included BMI percentile with age and with SBP.  We had originally hypothesized that, 
similar to annual well child visits, risk predictions models would be most relevant to 
specific chronological ages.  Nonetheless, using an independent group t-test, no 
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differences were found when comparing CVD risk factor beta coefficients in GEE models 
modeling: 1) chronological age (year), or 2) developmental age according to the 
American Academy of Pediatrics definitions of early (11-14 years), middle (15-17 years), 
or late adolescence (18-21 years).179  Consequently, our final GEE risk prediction model 
included age as a continuous variable.   
Model performance was evaluated using: (i) graphical representation comparing 
observed and predicted cIMT decile means as a measure of calibration (consistency 
between predicted and observed mean cIMT), and (ii) Spearman’s correlation coefficient 
of observed and predicted cIMT means as a global measure of discrimination (the ability 
of the prediction model to differentiate individuals with and without subclinical 
atherosclerosis).180,181  In sensitivity analyses, quadratic and cubic terms were included 
for all CVD risk factors to determine if calibration was improved by adding non-linear 
terms that were significantly associated with cIMT with p<0.05.  In the absence of an 
external validation sample, we used bootstrapping with replacement (n=1000 replicates) 
for optimism correction that would be expected when generating a risk prediction model 
on the estimation sample.181 Spearman correlation coefficients were generated for each 
bootstrapped replicated and plotted to examine the overall distribution; a 95% 
confidence interval was estimated by identifying values at the 2.5% and 97.5% of the 
distribution.  All analyses were performed using Stata 14 and R software packages.182,183 
 
Results 
 Table 2.1 describes the baseline characteristics of study participants (n=444, mean 
age: 12±3 years) by cIMT quartile.  Mean cIMT was 642±74 µm and 437±24 µm in 
quartiles 4 and 1, respectively.  Individuals in the highest quartile of cIMT were more 
likely to be male, black, and have a higher BMI and weight compared to the lowest 
quartile.  A modest increase in SBP was seen across quartiles; mean DBP was 
consistent across quartiles.  Differences in cIMT by cardiovascular risk factor are 
reported in Table 2.2.  In Model 2, female sex was associated with a lower cIMT (-27.3 
µm; 95% CI: -42.9, -11.7), whereas black race (37.6 µm; 95% CI: 16.1, 59.1), higher BMI 
percentile (0.24 µm; 95% CI: -0.27, 0.51, per 10% increase), and SBP (7.6 µm; 95% CI: 
1.9, 10.3, per 10 mmHg increase) were all associated with an increased cIMT.  Despite 
the fact that age, DBP, and height did not meet standard thresholds for statistical 
significance, we included them in our final risk prediction model based on a priori 
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literature review and because we had a limited number of variables to consider.  We 
chose Model 3 as our final model due to significant non-linear associations (SBP) and 
interaction terms (BMI percentile*age; BMI percentile*SBP). 
To examine model performance, we plotted observed and predicted mean cIMT 
decile values to assess calibration (Figure 2.1), and the distribution of Spearman’s 
correlation coefficients between observed and predicted cIMT by individual clinic visit to 
examine discrimination (Figure 2.2).  Overall calibration of our risk prediction model in 
the estimation sample was poor, as depicted by the discrepancy between what would be 
perfect calibration (i.e. a slope of 1.0) and the observed versus predicted mean cIMT 
decile values (Figure 1).  Though both quadratic and cubic terms for SBP met thresholds 
for statistical significance, the calibration plot remained unchanged when the non-linear 
terms were added to the model.  When assessing discrimination, Spearman correlation 
coefficients did not change dramatically by clinic visit, and were also weak (range: 0.33-
0.43; Figure 2.2).  Using bootstrapped replicates of the estimation sample, the 
distribution of correlation coefficients between observed and predicted mean cIMT 
values was normally distributed (mean 0.32; 95% CI: 0.30, 0.34) (Figure 2.3). 
    
Discussion 
Although longitudinal associations were observed between most CVD risk factors in 
adolescence and increased cIMT in middle adulthood, our risk prediction model 
evaluating the ability of CVD risk factors in adolescence to predict cIMT in middle 
adulthood performed poorly based on calibration and discrimination metrics.  
Nonetheless, predicting subclinical CVD based on risk factors in youth is important in 
that it facilitates assessment of risk for individuals who would benefit from earlier or 
specific treatments, and provides an easy tool for clinicians and researchers to use to 
determine appropriate treatments (behavioral, pharmacological, etc.).  
In particular, it is unclear why BMI percentile had a small magnitude of effect when 
we examined the association between CVD risk factors in adolescence and cIMT in 
middle adulthood.  The prevalence of obesity in childhood is high, with an overall 
prevalence in 2013-2014 of 17.4% in 6-11 year olds and 20.6% in 12-19 year olds.5 
Childhood obesity tracks into adulthood,11,184,185 and is associated with insulin 
resistance,30,186,187 impaired glucose,188 dyslipidemia,189 and blood pressure.58 
Furthermore, Mendelian randomization studies confirm that adiposity is a causal risk 
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factor for cardiovascular risk factors and atherosclerosis in adulthood.190,191 A recent 
longitudinal study in 2.3 million obese adolescents reported a 3.5 times higher lifetime 
risk of CVD mortality (95% CI: 2.9-4.1),69 and a 17.2 times higher risk of diabetes 
mortality in midlife (95% CI: 11.9-24.8).70  Finally, numerous longitudinal pediatric cohort 
studies have reported and association between BMI in youth, and cIMT in middle 
adulthood.57–59 It is possible that, on average, the participants in the PHBPC cohort had 
a healthy weight status; even in the highest quartile of cIMT the mean BMI and BMI 
percentile were 21±5 kg/m2 and 68±25th percentile, respectively (Table 2.1).  In the 
Young Finns study, for example, baseline BMI was 26±4 for males and 25±4 for 
females.  If few PHBPC participants had overweight or obesity, it would be difficult to 
assess the impact of excess adiposity on cIMT.  Finally, BMI percentile is the preferred 
indicator for adiposity in childhood in adolescence;192,193 other pediatric cohorts 
commonly used BMI as a measure of adiposity57–59 which could have resulted in biased 
estimates.194 
Two recent longitudinal studies in adolescents are the first to support an association 
between cardiovascular risk factors in adolescence and increased cIMT early in life, and 
may offer context for some of our results.67,68  The first, in 313 Aboriginal Australian 
children and adolescents (mean age: 11 ears) with metabolic syndrome, found that cIMT 
increased by 22 µm over 6 years (p=0.0007) but only in participants with C-reactive 
protein above the median.67 Using logistic regression, the authors found that an 
interaction between metabolic syndrome and C-reactive protein was responsible for 
increased cIMT at follow-up.  The impact of inflammation on vascular disease has been 
previously described,195,196 data examining inflammatory risk factors in youth with 
subclinical vascular outcomes in adulthood, however, are lacking.  In the current study, 
inflammation was not assessed; since excess adiposity catalyzes an inflammatory 
response,196 systemic inflammation may not have been extensive enough in PHBPC 
participants for subclinical cardiovascular disease to be present.  In the second study 
examining risk factors and cIMT in youth, 42 Swedish adolescents (mean age: 14 years; 
28 and 14 obese and lean participants, respectively) reported that radial-carotid IMT 
increased by 20 µm in participants with obesity, over only 5 years (p=0.04).68 Although 
informative, these results were unadjusted for other CVD risk factors so may be 
confounded, and were in the radial versus common carotid artery.  Though one was in a 
minority population67 and the other had a small sample size,68 taken together these 
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results support the premise that metabolic dysfunction and excess adiposity have an 
impact on cIMT in adolescence.  In the current analysis SBP had the largest magnitude 
of effect; these results are consistent with previous literature supporting an independent 
effect of SBP on cIMT in youth197 and adulthood.58,198  
Although we included what we believed to be the primary CVD risk factors for 
increased cIMT in middle adulthood, it is likely that our risk prediction model was lacking 
important candidate variables that are associated with, or are potentially relevant to cIMT 
in the literature.  Primarily, low-density lipoprotein cholesterol,57,58 smoking,58 dietary 
intake,199,200 physical activity,201,202 socioeconomic status,203,204 pubertal timing,205,206 and 
baseline arterial diameter in adolescence.55  Based on findings from two pediatric cohort 
studies, the presence of dyslipidemia and current smoking/secondhand smoke exposure 
were both independently associated with cIMT in middle adulthood.57,58  Evidence is 
lacking on the impact of diet on cIMT early in life, but studies in adults indicate that both 
a Mediterranean diet199 and a diet low in saturated fats and carbohydrates200 are 
associated with lower cIMT.  Literature examining the association between physical 
activity and cIMT in adolescence are mixed; in the European Youth Heart Study no 
association was found,201 but the Brazilian Birth Cohort study reported that physical 
activity in young adulthood was inversely associated with pulse wave velocity, another 
indicator of vascular health.202  Lower socioeconomic status in youth was associated 
with metabolic syndrome, higher impaired fasting glucose, and type 2 diabetes;207,208 
lower summary measures of psychological well-being, which included socioeconomic 
status, in childhood has been shown to be associated with increased cIMT209and 
coronary artery calcification210 in middle adulthood.  Evidence on the impact of pubertal 
status and cIMT is sparse; two studies that collected pubertal status did not find 
increases in cIMT during puberty,205,206 though one was in children with Type 1 diabetes 
mellitus.205  Finally, the protocol for cIMT measurements in our study protocol are known 
to be conservative; it is possible that the extent or severity of subclinical atherosclerosis 
was not fully captured by measuring mean cIMT of a single anatomical location 
(common carotid artery).55  In adults, differential effects of CV risk factors on distinct 
segments of the carotid artery have been reported; blood pressure was more strongly 
associated with common cIMT variability than other segments, while LDL-C tended to 
correlate more with the bulb and internal segments.211  It is unclear if these disparate 
effects exist in youth, nonetheless it is a possibility that warrants consideration. 
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This project has a number of limitations.  First, not all candidate CVD risk factor 
variables were available in this cohort.  The post-mortem PDAY risk prediction model in 
youth included age (5 years), male sex, non-HDL cholesterol, HDL cholesterol, smoking, 
hypertension, obesity, and hyperglycemia.150  The PDAY risk score had reasonable 
discrimination (c-index: 0.78) and calibration (goodness-of-fit statistics).150  Current 
evidence in longitudinal pediatric cohort studies suggests that BMI, SBP, and 
dyslipidemia have the greatest impact on development of subclinical atherosclerotic 
disease.57–59 Although we included BMI percentile and SBP in our final model, total 
cholesterol or low-density lipoprotein cholesterol were not collected.  Second, while the 
study was designed to obtain a racially diverse study sample with a wide distribution of 
blood pressure values, the results are likely not generalizable to a broader adolescent 
population.  Unfortunately, we did not have access to another dataset to perform 
external validation.  Nonetheless, we ran bootstrapped replicates in an effort to correct 
for expected optimism in our results.  Third, given that losses to follow-up are notable, 
the possibility of selection bias is likely.  Fourth, the clinical utility of cIMT is uncertain; 
questions remain regarding normative values and which populations would receive the 
greatest benefit from vascular imaging.  Fifth, standardized quantitative approaches to 
assess model performance metrics (calibration and discrimination) in risk prediction 
models with continuous outcomes are lacking.  For example, use of the c-statistic affords 
predetermined definitions of acceptable (0.7≤ c< 0.8) or excellent (0.8 ≤ c < 0.9) 
discrimination for dichotomous outcomes.181  Finally, the proposed risk prediction model 
does not account for measurement error in: (i) risk factors used in the model, or (ii) 
subclinical vascular measurements.  Strengths of this analysis include the collection of a 
CVD risk factor profile from adolescence through middle adulthood, a conservative 
estimate of cIMT by using mean cIMT of the entire area measured (versus maximum 
cIMT), and state-of-the-art software that provided improved resolution of cIMT and 
increased precision in measurement. To the best of our knowledge, this project is the 
first to evaluate a risk prediction model using CVD risk factors in adolescence and 
subclinical atherosclerosis is middle adulthood.    
If a risk prediction model for subclinical atherosclerosis was developed that met 
appropriate model performance metrics, it could impact the management of children and 
adolescents at risk for development of subclinical atherosclerosis. First, individuals with 
high-risk scores could be differentiated from those with low-risk scores without having to 
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measure vascular pathology. As a result, treatment optimization could be more tailored 
for high-risk individuals. Second, risk factor treatment (behavioral or pharmacological) 
could be monitored over time, thereby allowing for a more personalized approach to 
prevention and management of atherosclerosis. The risk prediction model we evaluated 
did not meet standard criteria for appropriate model performance, and thus it is not 
worthwhile to consider for clinical utility.  Nonetheless, it may be beneficial for future 
research efforts to consider risk prediction models for subclinical atherosclerosis in 
younger populations using longitudinal pediatric cohort studies with more robust CVD 
risk factor collection.   
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Table 2.1. Selected baseline participant characteristics by carotid intima-media 
thickness (cIMT) quartile, Prevention of High Blood Pressure in Children study 
(n=444). 
 Carotid intima-media thickness Quartile (cIMT) 
Category Q1 Q2 Q3 Q4 
N (Total) 112 131 93 108 
cIMT, µm (SD) 437 (24) 488 (15) 541 (16) 642 (74) 
cIMT, µm range 320-460 470-510 520-570 580-930 
Age, years (SD) 11.9 (3) 12.0 (3) 11.9 (3) 12.1 (3) 
Sex, female, N (%) 73 (65) 71 (54) 35 (38) 46 (43) 
Race, white, N (%) 77 (69) 96 (73) 59 (63) 59 (55) 
BMI, kg/m2 (SD) 19.0 (3.6) 20.0 (4.6) 19.4 (4.1) 21.1 (4.8) 
BMI, % (SD) 51 (28) 58 (29) 56 (29) 68 (25) 
Height, cm (SD) 149 (17) 152 (17) 151 (17) 153 (17) 
Height, % (SD) 45 (30) 54 (30) 52 (27) 55 (27) 
Weight, lbs (SD) 96 (35) 107 (42) 102 (40) 113 (42) 
SBP, mm Hg (SD) 107 (10) 110 (11) 110 (11) 112 (10) 
DBP, mm Hg (SD) 63 (13) 62 (14) 62 (14) 62 (14) 
Abbreviations and units: Carotid intima-media thickness, cIMT; micrometers, µm; standard deviation, SD; 
body mass index, BMI; kilograms/meters squared, kg/m2; centimeters, cm; percentile, %; millimeters of 
mercury, mm Hg; systolic blood pressure, SBP; diastolic blood pressure, DBP. 
 
Table 2.2. Differences in carotid intima-media thickness (cIMT) by cardiovascular 
risk factor, Prevention of High Blood Pressure in Children study (n=444). 
 Difference in cIMT, in µm (95% confidence interval) 
 Model 1 Model 2 Model 3 
Intercept 435 (379, 490) 435 (380, 492) 1765 (616, 2913) 
Age, years  -0.18 (-1.0, 0.62) -0.10 (-0.92, 0.72) -2.89 (-5.01, -0.77) 
Sex, female -27.3 (-42.8, -11.7) -27.3 (-42.9, -11.7) -27.4 (-42.9, -12.0) 
Race, black 38.1 (16.6, 59.5) 37.6 (16.1, 59.1) 36.9 (15.5, 58.2) 
BMI, %  0.28 (0.19, 0.54) 0.24 (-0.27, 0.51) 1.19 (-0.65, 3.0) 
SBP, mm Hg 8.4 (2.7, 10.4) 7.6 (1.9, 10.3) -36.0 (-66.6, -5.4) 
DBP, mm Hg -2.3 (-5.2, 0.5) -2.3 (-5.2, 0.5) -2.2 (-5.0, 0.7) 
Height, % - 0.15 (-0.095, 0.40) 0.17 (-0.79, 4.2) 
SBP2 - - 0.34 (0.065, 0.62) 
SBP3 - - -0.0001 (-0.002, -0.0002) 
BMI%*age - - 4.5 (1.5, 7.5) 
BMI%*SBP - - -1.4 (-3.2, 0.46) 
Abbreviations and units: Carotid intima-media thickness, cIMT; micrometers, µm; standard deviation, SD; 
body mass index, BMI; kilograms/meters squared, kg/m2; centimeters, cm; percentile, %; millimeters of 
mercury, mm Hg; systolic blood pressure, SBP; diastolic blood pressure, DBP; quadratic term for systolic 
blood pressure, SBP2; cubic term for systolic blood pressure, SBP3; interaction term for BMI percentile and 
age, BMI%*age; interaction term for BMI percentile and SBP, BMI%*SBP. 
Unit interpretation: All coefficients are presented as a one unit change with the exception of: 1) BMI and 
height percentile variables: 10 percentile unit change, and 2) SBP and DBP: 10 mm Hg unit change. 
Model 2: Model 1 + height % 













Figure 2.2. Spearman’s correlation coefficients between observed and predicted 











Figure 2.3. Distribution of Spearman’s correlation coefficient1 between observed 
and predicted mean cIMT from bootstrapped replicate samples (n=1000). 
 
195% CI: 0.30-0.34 
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Paper 2: Cardiovascular Risk Factors in Adolescence and Young Adulthood and 
Common Carotid Artery Intima-Media Thickness in Early and Middle Adult Life 
 
Introduction 
 Atherosclerosis has been shown to begin early in life,1 most often with the presence 
of fatty streaks in the intimal layer of the arteries.212 Aortic fatty streaks have been 
identified as early as 3 years of age213 and increase with age.214 In addition, coronary 
artery atherosclerotic plaques have been documented during adolescence.215 Cross-
sectional autopsy results from the Pathological Determinants of Atherosclerosis in Youth 
Study confirm that atherosclerosis is present in childhood; cardiovascular risk factor 
burden is associated with the extent and severity of atherosclerosis in youth.44–46  
 Cardiovascular risk factors such as obesity, Type 2 diabetes mellitus, and 
hypertension are strongly associated with adult cardiovascular disease (CVD).1,94,216 
Previously considered diseases of adulthood, prediabetes158,159, Type 2 diabetes160,161, 
dyslipidemia25,162,163, and  hypertension164,165 have been increasing in adolescence, 
primarily in parallel with the obesity epidemic.166,167 A recent study in 2.3 million 
adolescents found that adolescent obesity was associated with a 3.5 times higher 
lifetimes risk of CVD mortality (95% CI: 2.9-4.1);69 obesity in adolescence was also 
associated with a 17.2 times higher risk of diabetes mortality in midlife (95% CI:11.9-
24.8).70 Overt CVD events, however, are rare in childhood.1,9 Consequently, subclinical 
cardiovascular outcomes such as carotid intima-media thickness (cIMT) have become 
widely accepted as relevant to earlier stages of CVD.55 Several cohort studies have 
measured cardiovascular risk factors in children and evaluated cIMT in midlife (33-39 
years of age).57–59 They consistently found that presence of CVD risk factors in childhood 
and adolescence were associated with increased cIMT in middle adulthood.58,61,122,220 A 
recent cross-sectional study found that presence of obesity or diabetes mellitus in 
adolescence was associated with an increased internal cIMT compared to their lean 
non-diabetic counterparts.219  
 Although the association between childhood CVD risk factors and increased cIMT in 
adults in their mid-30’s has been established, only two longitudinal studies have 
examined vascular health outcomes in early life. In a recent study of 313 Aboriginal 
Australian adolescents 9 to 13 years old with metabolic syndrome, cIMT increased by 22 
µm over 6 years (p=0.0007).67 A second study of 42 obese Swedish adolescents (mean 
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age: 14 years) documented a 20 µm increase in cIMT over only 5 years (p=0.04).68 
Although informative, one was limited to a unique minority population67 and the other 
had a small sample size.68 Therefore, our objective was to add to the existing literature 
by: (i) to examining the association between CVD risk factors in adolescence and cIMT 
in young adulthood (early 20’s) in a larger bi-racial cohort study, and (ii) to evaluate the 
association between CVD risk factors in young adulthood (mid 20’s) and cIMT in middle 
adulthood (mid-30’s).  We hypothesized CVD risk factors at all ages would be 
associated with increased cIMT in early (mid-20’s) and middle adulthood (mid-30’s). 
 
Methods 
Cohort Descriptions  
Insulin Study (InS) 
 The Insulin Study (InS) is a longitudinal prospective cohort study initiated at the 
onset of the 1995-96 school year in Minneapolis Public Schools (Table 3.1).220 Three 
follow-up exams were conducted: (i) visit 2 (1997-98), (ii) visit 3 (1999-2000), and (iii) 
visit 4 (2004-09). The cohort was randomly selected from all incoming students in 5th 
through 8th grades who participated in a school-wide blood pressure (BP) screening 
program (n=2,915). From the initial BP screening, strategic attempts were made to 
acquire a higher proportion of children with the potential for future CV risk. The cohort 
was stratified by sex, ethnicity (non-Hispanic white and black), and 75th systolic blood 
pressure percentile cut point (50% whose screening systolic blood pressure was above 
the 75th percentile of its observed distribution, and 50% whose screening systolic blood 
pressure was below this cut point). To increase sample size, siblings of all original 
participants were eligible to participate in the InS starting in 2000. Inclusion criteria for 
participation included: (i) probands: participated in the initial 1995-96 study exam, and (ii) 
siblings: siblings of the original participants. At each study visit, participants underwent 
extensive clinical examinations; cIMT was assessed at visit 4.  For the current analysis, 
we used visit 2 as baseline (mean age: 15 years) and visit 4 as follow-up (mean age: 23 
years). 
Prevention of High Blood Pressure in Children (PHBPC) 
 The Prevention of High Blood Pressure in Children (PHBPC) study was previously 
described in Paper 1; Table 3.1 provides a brief summary of both cohort studies in the 
current analysis.  In brief, PHBPC is a longitudinal cohort study that was initiated at the 
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onset of the 1977-78 school year in Minneapolis Public Schools. Basic anthropometric 
data were collected annually through high school; three additional visits occurred: (i) visit 
2 (1989-91), (ii) visit 3 (1991-95), and (iii) visit 4 (2007-11).170 The cohort was randomly 
selected from all incoming students in 1st through 3rd grades (n=2641). In an attempt to 
enroll participants at increased risk of future CVD, study investigators used the followed 
selection criteria: (i) all children at the upper and lower 5th percentiles of the normal 
systolic BP distribution, (ii) 50% of the African American children that remained, and (iii) 
10% of the white children that remained.  Comprehensive clinical exams were completed 
at visits 2-4; cIMT was assessed at visit 4.  For the current analysis, we used visit 3 as 
baseline (mean age: 23 years) and visit 4 as follow-up (mean age: 38 years). 
 The University of Minnesota Institutional Review Board approved both cohorts and 
all exams were conducted with written informed consent (from parents when children 
were below 18 years old, with verbal assent from the children; from the participants 
themselves after they came of age). All methods of exposure, outcome, and covariate 
assessment were identical in both studies unless otherwise noted. 
Exclusions and Missing Data 
Insulin Study (InS) 
Baseline exclusion criteria included: (i) currently pregnant, (ii) Type 1 diabetes 
mellitus, (iii) kidney dialysis or end-stage renal disease patients, (iv) cancer patients, or 
(v) other chronic diseases that have an impact on the study measurements as deemed 
appropriate by study investigators.220,221 Of the original 2915 participants randomly 
selected, 401 children provided written consent or parental assent. Of these 401 
participants, 357 remained after exclusions (44 were excluded for the following reasons: 
25 withdrew from participation, 2 were ineligible due to chronic disease, 17 were too 
technically difficult to establish a venous catheter for the clamp studies at the University 
of Minnesota Clinical and Translational Science Institute). Siblings were recruited for 
participation and examined only in visits 3 and 4, and had a slightly broader age range 
(11-35 years of age). Siblings that matched the baseline proband age range were 
included in the analysis.  For the present study, we used visit 2 (n=512; proband n=357, 
sibling n=155) as baseline and visit 4 (n=317; proband n=215, sibling n=102) as the 
follow-up visit. The final sample size consisted of 317 participants. 
Prevention of High Blood Pressure in Children (PHBPC) study 
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PHBPC exclusions and missing data were previously described in Paper 1.  In brief, 
of the 2641 children randomly selected to participate in the cohort, 1207 met inclusion 
criteria and provided written informed consent for participation using University of 
Minnesota Institutional Review Board approved documents.  Participants were examined 
twice yearly until high school; at which time they were examined annually.  A post-high 
school examination was conducted on average 2 years after graduation (mean age: 19 
years); at this exam 817 individuals participated.  Baseline characteristics did no differ 
between the 817 individuals who participated and the 319 individuals lost to follow-up.  
At the most recent clinic visit in 2007-11 (mean age: 38 years), a comprehensive 
cardiovascular profile that included cIMT was collected on 444 participants; our final 
sample size was 444 observations. 
Cardiovascular Disease Risk Factors 
Anthropometrics & Blood Pressure 
Two seated systolic blood pressure (SBP) and diastolic blood pressure (SBP) 
measurements were taken at the right brachial artery using a random zero 
sphygmomanometer; an average of these two measurements was used for all analyses. 
Weight was measured using a medical grade balance scale without shoes; height was 
measured using a standing stadiometer to the nearest millimeter. Pulse pressure (PP) 
was defined as the difference between systolic and diastolic blood pressure. 
Fasting Laboratory Studies (cholesterol, glucose, insulin, and HOMA) 
Fasting blood samples were drawn using standard phlebotomy procedures to 
measure: total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density 
lipoprotein cholesterol (HDL-C), triglycerides, and glucose. Non-HDL cholesterol (non-
HDL-C) was defined as the difference between total cholesterol and HDL-C.  Whereas 
PHBPC measured fasting insulin, the InS collected euglycemic insulin clamp data, the 
gold standard for measuring insulin resistance.222 Homeostasis model assessment 
(HOMA) was defined as: (glucose*insulin)/405.223 
Sociodemographics 
Age, race, and sex were collected by self-reported questionnaires. Age was asked 
to the nearest year; race was categorized as non-Hispanic white or African American.  
No measures were collected for parental socioeconomic status. 
Pubertal Timing 
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Puberty was not assessed in PHBPC through the high school clinic visit. After the 
high school visit, participants were asked to report pubertal development using a visual 
scale that parallels classic Tanner development stages.224,225 In the InS, board certified 
pediatricians conducted a physical exam to assess Tanner stages of pubertal 
development. Children were divided into Tanner stages according to pubic hair and 
breast development in girls, and pubic hair development in boys. In girls, whichever 
Tanner stage was higher (pubic hair or breast development) was used.226 
Carotid Intima-media Thickness 
 All vascular health assessments were performed in a quiet room at a comfortable 
temperature (22-23°C); cIMT was collected at the final exam in both InS and PHBPC, 
2004-09 (mean age: 23 years) and 2007-11 (mean age: 38 years) respectively at the 
University of Minnesota Clinical and Translational Science Institute. Participants were 
asked to refrain from caffeine and medication consumption prior to their scheduled clinic 
visit. After lying in a supine position for 15 minutes, a standard high-frequency 
ultrasound (Siemens, Sequoia 512, New York, NY) using an 8-15 MHz linear array 
transducer was used to capture B-mode images of the far wall of the left common carotid 
artery. Images for determining cIMT were obtained at end-diastole (gated by R wave on 
ECG). Measurements were obtained at the distal 10 mm of the common carotid artery 
as recommended by pediatric guidelines.55 An electronic wall-tracking software program 
(Medical Imaging Applications, Coralville, IA) was used for the analysis of cIMT. Mean 
cIMT was calculated by averaging individual cIMT values over the entire length of the 
arterial measurement area. Our laboratory has previously documented satisfactory cIMT 
reproducibility, with the mean difference for repeated measurements on separate days in 
the same subjects of 0.02 ± 0.03%.227  
Statistical Analysis 
For both studies, descriptive statistics were calculated: (i) stratified by quartiles of 
cIMT, and presented as mean ± standard deviation (SD) or as a frequency distribution 
(%) of cardiovascular disease risk factor, and (ii): stratified categorically or by quartiles 
(continuous variables) of cardiovascular disease risk factor, and presented as mean ± 
standard deviation (SD) of cIMT. For both studies we examined the association between 
a one SD unit difference in CV risk factors and cIMT, adjusting for potential confounding 
variables. Consensus is lacking in regards to the best modeling approaches for vascular 
health measurements. We chose to model cIMT continuously; CV risk factors were 
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transformed into standardized z-scores to facilitate comparison between CV risk factors. 
For the InS, we used multivariable Generalized Estimating Equations (GEE) models to 
account for correlation between siblings.  Siblings were included if they fell in the same 
age range as probands - 12 to 18 years of age (excluded: n=17, age 11; n=92 age 19 or 
older). GEE model specifications included a Gaussian family, a canonical identity link, an 
independent working correlation matrix and a robust standard variance estimator.  For 
the PHBPC, no siblings were included; multivariable linear regression models were 
used.  In all analyses, we fit two models: (i) Model 1 adjusted for baseline age, sex, race, 
Tanner stage (InS longitudinal analysis only), and each cardiovascular risk factor 
independently; (2) Model 2 adjusted for baseline age, sex, race, Tanner stage (InS 
longitudinal analysis only), and all cardiovascular risk factors concurrently.  We excluded 
pulse pressure, LDL-C, triglycerides, glucose and insulin in Model 2 due to collinearity 
with other variables in the model.  In both cohorts, cross-sectional and longitudinal 
analyses were conducted. Exploratory analyses examined results stratified by sex and 




 Of the 317 InS and 444 PHBPC participants included in our analysis, mean cIMT 
was higher in PHBPC (527±32 µm) than in InS (444±22 µm), respectively.  Table 3.2 
shows study-specific descriptive statistics for baseline variables presented by cIMT 
quartile. By design, participants in InS were younger at baseline (mean age: 15 years) 
compared to the PHBPC (mean age: 23 years); baseline age was similar in cIMT 
quartiles 1 and 4 (Q1 and Q4) in both studies. Participants in InS and PHBPC were 
predominantly non-Hispanic white, with lower proportions of females and higher 
proportions of blacks in quartiles 3 and 4 of cIMT.  In both studies, participants in cIMT 
Q4 had higher BMI percentile or BMI, systolic blood pressure (SBP), LDL-C, non-HDL-C, 
triglycerides, glucose, insulin, and HOMA than those in cIMT Q1 (Table 3.2).   
In InS (Table 3.3), black participants had a 45.4 µm (95% CI: 13.7, 77.0; p<0.005) 
and 29.9 µm (95% CI: 13.7, 46.1; p<0.0001) higher cIMT than white participants in a 
demographic (Model 1) and fully adjusted model (Model 2), respectively.  A one 
standard deviation unit difference in BMI percentile z-score (27.0%) at age 15 was 
associated with a 9.6 µm (95% CI: 4.8, 14.5; p<0.0001) higher cIMT at age 23 after 
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adjusting for demographics.  The association was similar, though slightly attenuated, in a 
fully adjusted model (6.9 µm; 95% CI: 1.1, 12.6; p=0.02).  After adjusting for 
demographics, a one standard deviation unit difference in non-HDL-C z-score (29.5 
mg/dL) at age 15 was associated with a 5.9 µm (95% CI: 1.4, 10.4; p=0.01) higher cIMT 
at age 23; this association became slightly attenuated after adjusting for other 
cardiovascular risk factors (5.5 µm; 95% CI: -0.07, 11.0; p=0.05).  An association 
between a one standard deviation unit difference in HOMA z-score (2.1) at age 15 and 
cIMT at age 23 was present (7.1 µm; 95% CI: 2.8, 11.5; p=0.001) after adjusting for 
demographics, but was also attenuated after further adjustment for cardiovascular 
disease risk factors (5.6 µm; 95% CI: -0.43, 11.5; p=0.07).  No association was found 
between other cardiovascular risk factors z-scores and cIMT (SBP, DBP, or HDL-C) in 
the fully adjusted model.   
In PHBPC (Table 3.4), a one standard deviation unit difference in age (1.5 year) 
was associated with a higher cIMT in a demographics adjusted model (5.9 µm; 95% CI: 
0.89, 11.1; p=0.02); this association was attenuated after adjusting for cardiovascular 
risk factors (5.0 µm; -0.60, 10.6; p=0.08). Female participants had a lower cIMT (-26.7; 
95% CI: -44.4, -9.1; p=0.003) and blacks had increased cIMT (45.3 µm; 95% CI: 24.8, 
65.8; p<0.0001) in fully adjusted models.  A one standard deviation unit difference in 
BMI z-score (5.8 kg/m2) at age 23 was associated with a 10.9 µm (95% CI: 2.7, 19.0; 
p=0.009) higher cIMT at age 38 after adjusting for demographics; the association 
disappeared after adjusting for other cardiovascular risk factors was attenuated in a fully 
adjusted model (-1.2 µm; 95% CI: -11.5, 9.2; p=0.83).   
SBP, however, was associated with cIMT; a one standard deviation unit difference 
in SBP z-score (10.8 mm Hg) was associated with a 17.0 µm higher cIMT in the 
demographics (95% CI: 8.8, 25.1; p<0.0001) and 21.0 µm higher cIMT in the fully 
adjusted model (95% CI: 10.3, 31.8; p<0.0001).  After adjusting for demographics, a one 
standard deviation unit difference in HOMA z-score (4.4) at age 23 was associated with 
a 9.4 µm (95% CI: 0.82, 18.1; p=0.002) increase in cIMT at age 38; this association was 
attenuated in the fully adjusted model (5.8 µm; 95% CI: -3.9, 15.6; p=0.24).  No other 
cardiovascular risk factors (DBP, HDL-C, non-HDL-C) were associated with increased 
cIMT.  In both studies, cross-sectional results were nearly identical to longitudinal results 




 In both the InS (Table 3.3) and PHBPC (Table 3.4), we found that black participants 
had a higher cIMT compared to white participants after adjusting for demographics and 
cardiovascular risk factors.  In InS, a one standard deviation unit increase in BMI 
percentile z-score (27.0 %) at mean age 15 was associated with elevated cIMT at mean 
age 23 in a fully adjusted model. In PHBPC, a one standard deviation unit increase in 
BMI z-score (5.8 kg/m2) at mean age 23 was associated with a higher cIMT at mean age 
38 in a demographics adjusted model.  When adjusting for additional cardiovascular 
disease risk factors, no association was found between BMI and cIMT.  SBP, however, 
was associated with higher cIMT; a one standard deviation unit difference in SBP z-
score (10.8 mm Hg) at mean age 23 and cIMT at age 38 persisted in the fully adjusted 
model. In InS, after adjustment for cardiovascular risk factors, a one standard deviation 
unit increase in a non-HDL-C z-score (29.5 mg/dL) at mean age 15 was marginally 
associated with increased cIMT at mean age 23; no association between non-HDL-C 
and cIMT was found in PHBPC. These results extend the newly emerging evidence that 
BMI percentile in adolescence is associated with increased cIMT earlier in life than was 
previously thought, and provides evidence that systolic blood pressure may mediate the 
association between BMI and cIMT in middle adulthood.  
A longitudinal study in 2.3 million adolescents reported a 3.5 times higher lifetime 
risk of CVD mortality (95% CI: 2.9-4.1),69 and a 17.2 times higher risk of diabetes 
mortality in midlife (95% CI:11.9-24.8) in obese participants.70 Overt CVD events are 
uncommon in childhood.1,9 Therefore, emphasis has been placed on subclinical 
atherosclerosis as it represents an intermediate step in the pathophysiology from the 
presence of CV risk factors to frank CVD.55 Two recent studies are the first to support an 
association between cardiovascular risk factors in adolescence and increased cIMT 
early in life.67,68 One, in 313 Aboriginal Australian children and adolescents (9 to 13 
years) with metabolic syndrome, found that cIMT increased by 22 µm over 6 years 
(p=0.0007).67 The second, in 42 obese Swedish adolescents (mean age: 14 years) 
reported that cIMT increased by 20 µm, over only 5 years (p=0.04).68 Though one was in 
a minority population67 and the other had a small sample size,68 taken together these 
results support the premise that metabolic dysfunction and excess adiposity have an 
impact on vascular health in adolescence.  
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A number of well-known pediatric cohort studies have evaluated the impact of 
childhood risk factors and development of subclinical atherosclerosis in mid-adulthood. 
In the Bogalusa Heart Study, Li and colleagues found that a one standard deviation 
difference in childhood LDL cholesterol (OR: 1.42, 95% CI: 1.14-1.78) and BMI (OR: 
1.25, 95% CI: 1.10-1.54) were predictive of increased carotid intima media-thickness 
(upper quartile) in adulthood (25-37 years of age).57 Evidence from the Muscatine and 
Young Finns studies found similar results, emphasizing the impact of childhood risk 
factor burden on future subclinical CVD (age range: 33-42 years, and mean age: 31 
years, respectively).7,58,59 Collectively, these studies provide strong evidence that risk 
factor burden in childhood has vascular implications in middle adulthood. Our findings 
extend the understanding of the longitudinal impact of CV risk factors on vascular health 
to early adulthood (mean age: 23 years). In the current analysis, a one standard 
deviation unit difference in non-HDL-C was associated with increased cIMT in InS, but 
not in PHBPC.  Furthermore, LDL-C and was not associated with increased cIMT in 
PHBPC, triglyceride and log transformed triglyceride (to normalize right skewed nature 
of natural triglycerides) levels were not associated with cIMT in either study, and HDL-C 
was not protective in either study.  These results are consistent with a 2011 National 
Heart, Lung, and Blood Institute report on cardiovascular health in children and 
adolescents which concluded that non-HDL-C captures persistent dyslipidemia in 
adolescent populations more accurately than LDL-C or HDL-C levels.228 SBP was only 
associated with elevated cIMT in PHBPC, and appeared to mediate the association 
between BMI and cIMT. It is possible that lipid and blood pressure changes are not as 
influential on vasculature earlier in life, that they require a longer duration to elicit an 
effect (i.e. changes in BMI status generally occur prior to increases in blood pressure or 
lipids and therefore have a longer period of time to impact vasculature), or that our 
sample size is insufficient to detect a smaller magnitude of effect in young adulthood.  
Only 1 of the 3 longitudinal pediatric cohort studies has reported an association between 
high childhood SBP and cIMT in middle life.58 Nonetheless, two recent cross-sectional 
studies in adolescents found that elevated systolic blood pressure was independently 
associated with cIMT;229,230 one concluded that only age and blood pressure were 
responsible for the direct effects on elevated cIMT.229 A cross-sectional study in adults 
reported that hypertension status was most strongly associated with cIMT and degree of 
severity; an association was present, but to a lesser extent, with dyslipidemia and 
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diabetes and cIMT.231  Furthermore, a longitudinal study in adults found that a 5 mm Hg 
increase in SBP was associated with and 8 µm increase in cIMT (95% CI: 2.5, 14.0).232  
In short, more evidence is needed in regard to the complex relationship between BMI, 
SBP, and cIMT in both adolescent and adult populations.  
Recent evidence in adults provides insight into possible mechanisms by which 
childhood overweight and obesity may impact vascular health. Specifically, endothelial 
function appears to be a critical factor in predicting cardiovascular events, independent 
of conventional CV risk factors.233–235 A meta-analysis in adults determined that a 1% 
decrease in flow-mediated dilation predicted a 13% higher risk of cardiovascular 
disease.233 Furthermore, adipose tissue secretes pro-inflammatory cytokines such as 
interleukin-6, a known regulator of C-reactive protein, which is linked with inflammation 
and CVD.236 A cross sectional study in healthy adults found that adiposity status (normal 
weight vs. overweight and obese) was positively associated with C-reactive protein,237 
and observational data in adults suggests that C-reactive protein predicted an increased 
risk of CVD.238 Future examination of these factors in childhood and adolescent 
populations could be informative etiologically, particularly in the understanding of 
physiological mechanisms involved in subclinical CVD.   
 Strengths of the InS and PHBPC studies include collection of a comprehensive CV 
risk factor profile from adolescence through middle adulthood and an accurate estimate 
of cIMT by using: (i) mean cIMT of the entire area measured (versus maximum cIMT), 
and (ii) specialized software that allows greater resolution of arterial imaging. 
Importantly, InS measured cIMT in early adulthood (mean age 23 years) which is critical 
to establishing the impact of cardiovascular risk factor burden on vascular health in early 
adulthood. Finally, results from PHBPC are consist with other pediatric cohorts.57–59 
Limitations of both studies include potential unmeasured confounding (i.e. parental 
socioeconomic status, dietary intake, and physical activity levels), and the possibility of 
selection bias due to low response rates at the initiation of the study (despite a near 
complete census of school-aged children).  Smoking status was assessed in PHBPC 
(current, former, never) but not in InS.  Results were unchanged when we included 
smoking status in our PHBPC models, hence we excluded smoking status from our 
analyses for consistency.  Results may not apply to other ethnic groups beyond non-
Hispanic whites and African Americans.  Assessment methods for insulin were different 
in PHBPC (fasting insulin) and InS (euglycemic insulin clamp – gold standard); PHBPC 
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insulin measurements are likely not as accurate as those performed in InS.  Secondary 
to study design, age-matched siblings had short follow-up time (4.9 years) compared to 
probands (6.6 years), thus siblings may have had less follow-up time to accumulate 
changes in cIMT.  Finally, the clinical utility of cIMT is uncertain; questions remain 
regarding normative values and which populations would receive the greatest benefit 
from vascular imaging.  Epidemiological evidence suggests that elevated cIMT is 
associated with frank CVD events in adulthood; a meta-analysis in older adults reported 
that the age- and sex-adjusted risk of myocardial infarction and stroke were 1.15 (95% 
CI: 1.12, 1.17) and 1.18 (95% CI: 1.16, 1.21) per 0.10 mm change in cIMT, 
respectively.239 There are no studies to date examining the relationship between 
childhood or adolescent cIMT and risk of future CVD events. In a cross sectional 
analysis examining adolescents with Type 1 diabetes, mean cIMT was 0.55 ±0.04 mm 
compared to 0.51±0.04 mm in healthy participants (p<0.001) suggesting that a 
difference in cIMT of approximately 0.04 mm may have clinical implications in 
adolescence.240  Nonetheless, the magnitude of cIMT changes that have clinical 
implications in childhood and adolescence is uncertain, and presents a rich area for 
future research.     
 The implications of our results merit consideration of increased adiposity status in 
childhood and adolescence. National Health and Nutrition Examination Survey 
(NHANES) data suggest that 33% of children 2-18 years of age were overweight or 
obese; 17% were obese.167 The prevalence of pediatric overweight and obesity has 
been steadily increasing over the past 30 years, tracks into adulthood, and is positively 
associated with risk factors that predict cardiovascular disease morbidity and 
mortality.241–245 Furthermore, adiposity is known to track into adulthood more strongly 
than other risk factors; most children do not outgrow their adiposity status.44–47 Robust 
cross-sectional evidence suggests that obese children and adolescents have lower 
arterial health and endothelial function than their healthy counterparts.130,132,134,246,247 
Longitudinal pediatric cohort studies have established that overweight and obesity have 
vascular consequences in adulthood;57–59 our results support that these physiological 
implications are present earlier in adulthood than was known and that elevated adiposity 
is the biggest predictor of vascular dysfunction in adolescence. Preventive measures 
that improve vascular function may prevent future cardiovascular disease events by 
disrupting the development of atherosclerosis.248 
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Importantly, vascular changes have been shown to be reversible. In 2010, the 
American Heart Association (AHA) established strategic Impact Goals: “By 2020, to 
improve the cardiovascular health of all Americans by 20%, while reducing deaths from 
CVDs and stroke by 20%.”87 Independently, the development of the Ideal Cardiovascular 
Health (ICH) metric by the AHA substantiates the importance of primordial CVD 
prevention.249 Furthermore, using the AHA ICH metric, investigators from the Young 
Finns study demonstrated that a 1-unit increase in ICH in childhood (12-18 years) was 
associated with a 25% reduction in the odds of high carotid intima-media thickness 
(cIMT) (OR=0.75, 95% CI: 0.60-0.94, p=0.01). Notably, these results were independent 
of changes in ICH between childhood and adulthood.92 Finally, exercise appears to 
positively impact vascular health in obese and overweight children. In otherwise healthy 
youth 9-12 years of age, cIMT was reduced in the group randomized to an exercise 
program indicating that vascular dysfunction is at least partially reversible.133 A recent 
meta-analysis confirmed that exercise improves vascular function in overweight and 
obese children and adolescents, and that the magnitude of change was large enough to 
reestablish healthy vascular function.250 
In conclusion, elevated BMI beginning in adolescence was associated with 
increased cIMT in young adulthood. In the mid-20’s, SBP appeared to be associated 
with cIMT in the mid-30’s. These results suggest that youth is a critical period for 
detection and intervention to preserve future cardiovascular health.  Initiation of 
preventive strategies in adolescence and young adulthood, particularly in regard to 
adiposity and blood pressure, may reduce future subclinical atherosclerosis. Next steps 
include replication in other cohorts and further exploration of the most appropriate 
strategies for clinical adiposity management. 
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Table 3.1. Overview of the Insulin Study and Prevention of High Blood Pressure in 
Children (PHBPC) study. 
 Insulin Study PHBPC 
General study 
characteristics 








Grade level1 5th-8th 5th-8th 1st-3rd 
Location 
Minneapolis, MN Minneapolis, MN Minneapolis & 







    
Analys characteristics Probands Siblings  
Initial visit 1997-98 2000 1991-95 
Follow-up visit 2004-09 2004-09 2007-11 
CV risk factor assessment3 15 yrs 15 yrs 23 years 
cIMT assessment3 23 yrs 23 yrs 38 years 
Initial visit (n) 357 155 679 
Follow-up visit (n) 215 102 444 
Total sample size 317 444 
Abbreviations: cardiovascular, CV; Carotid intima-media thickness cIMT. 
1 Matched sibling age to probands in analytic sample (12-19 years). 
2 Stratified sampling of near complete school census, then low response rates; stratified by sex, race (non-
Hispanic white and black), and blood pressure (50% of children in upper 25th and 50% in lower 75th 
percentiles of normal systolic distribution). 
3 Mean; baseline age range: 12-19 years (Insulin) and 20-25 years (PHBPC); follow-up age range: 20-25 
years (Insulin) and 38-40 years (PHBPC)
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Table 3.2. Selected baseline participant characteristics; the Insulin Study and Prevention of High Blood Pressure in 
Children (PHBPC) study. 
 
 
Insulin Study PHBPC 
1997-2000; mean age 15 1991-95; mean age 23 
n=317 n=444 
Carotid intima-media thickness quartiles 
 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 
N 99 101 49 68 112 131 93 108 
Mean, µm ± SD 375 (37) 433 (7) 455 (5) 511 (38) 437 (24) 488 (15) 541 (16) 642 (74)   
Range, µm 220-410 420-440 450-460 470-640 370-460 470-510 520-570 580-940 
Age, mean years ± SD 15.5 (1.0) 14.7 (1.3) 14.5 (1.0) 15.6 (1.1) 23.0 (1.0) 23.1 (0.94) 23.0 (0.91) 23.2 (0.93) 
Female, n (%) 48 (49) 51 (51) 19 (39) 24 (35) 73 (65) 71 (54) 35 (38) 46 (43) 
Black, n (%) 11 (11) 10 (10) 15 (31) 20 (29) 21 (19) 25 (19) 24 (26) 38 (35) 
Tanner stage  
(1-4), n (%) 17 (17) 22 (22) 14 (29) 10 (15) - - - - 
BMI1 61 (27) 59 (29) 70 (22) 78 (21) 24 (5) 26 (7) 26 (5) 27 (6) 
SBP, 
mm Hg ± SD 108 (7) 107 (9) 108 (9) 111 (10) 107 (10) 110 (11) 113 (11) 115 (10) 
DBP, 
mm Hg ± SD 58 (13) 58 (14) 58 (15) 56 (13) 70 (9) 70 (10) 72 (10) 72 (10) 
PP, 
mm Hg ± SD 50 (15) 49 (15) 50 (18) 55 (17) 37 (8) 41 (9) 42 (9) 43 (9) 
LDL-C, 
mg/dL ± SD 83 (25) 87 (26) 83 (25) 89 (29) 103 (27) 102 (25) 108 (33) 108 (27) 
HDL-C, 
mg/dL ± SD 43 (9) 45 (9) 43 (9) 41 (8) 51 (13) 47 (12) 46 (11) 49 (11) 
Non-HDL-C, 
mg/dL ± SD 105 (29) 106 (30) 99 (25) 112 (32) 121 (31) 121 (31) 128 (37) 127 (32) 
Triglycerides, 
mg/dL ± SD 86 (37) 84 (45) 81 (32) 102 (53) 86 (44) 96 (63) 101 (56) 97 (66) 
Glucose, mg/dL ± SD 85 (5) 86 (6) 85 (7) 88 (8) 85 (8) 89 (16) 89 (9) 90 (8) 
Insulin, 
mU/L ± SD 10 (6) 12 (9) 11 (6) 13 (9) 19 (10) 19 (11) 20 (13) 22 (13) 
HOMA ± SD 2 (2) 3 (2) 2 (1) 3 (3) 4 (2) 4 (3) 5 (4) 5 (3) 
Abbreviations and units: quartiles 1, 2, 3 and 4, Q1, Q2, Q3, Q4, respectively; body mass index, BMI (kg/m2); systolic blood pressure, SBP (mm Hg); 
diastolic blood pressure, DBP (mm Hg); pulse pressure, PP (mm Hg); low-density lipoprotein cholesterol, LDL-C (mg/dL); high-density lipoprotein 
cholesterol, HDL-C (mg/dL); non-high-density lipoprotein cholesterol, non-HDL-C [total cholesterol – HDL-C]; homeostasis model assessment 
[insulin*glucose/405], HOMA. 
1BMI reported as age- and sex-adjusted percentile (SD) based on CDC growth curves in the Insulin Study and kg/m2 in the PHBPC. 
44  
Table 3.3. Differences in carotid intima-media thickness (cIMT, µm) by 
cardiovascular risk factor (z-score); Insulin Study (n=317). 
  Model 11 Model 22 
  Mean ages: 15 yrs at baseline; 23 yrs at follow-up. 
 SD Coef (95% CI) p-value Coef (95% CI) p-value 
Age 1.6 2.1 (-11.4, 7.2) 0.66 3.2 (-0.73, 7.1) 0.11 
Sex, female3 - -6.4 (-14.3, 27.1) 0.54 -7.7 (-18.4, 3.1) 0.16 
Race, black3 - 45.4 (13.7, 77.0) 0.005 29.9 (13.7, 46.1) <0.0001 
Tanner stage  -2.2 (-15.6, 11.2) 0.75 -0.34 (-12.1, 11.4) 0.96 
BMI %4 27.0 9.6 (4.8, 14.5) <0.0001 6.9 (1.1, 12.6) 0.02 
SBP 8.6 3.4 (-1.6, 8.4) 0.18 2.3 (-3.5, 8.1) 0.44 
DBP 12.8 2.7 (-1.7, 7.1) 0.23 0.38 (-4.6, 5.3) 0.88 
PP 15.2 -0.7 (-5.2, 3.9) 0.78 n/a5 n/a5 
LDL-C 26.0 5.5 (1.0, 10.0) 0.02 n/a5 n/a5 
HDL-C 9.2 -2.7 (-7.3, 1.9) 0.24 1.5 (-3.8, 6.9) 0.58 
Non-HDL-C 29.5 5.9 (1.4, 10.4) 0.01 5.5 (-0.1, 11.0) 0.05 
Triglycerides 53.0 5.2 (0.7, 9.8) 0.03 n/a5 n/a5 
Glucose 7.7 6.0 (-2.0, 14.0) 0.14 n/a5 n/a5 
Insulin 8.8 7.5 (3.3, 11.6) <0.0001 n/a5 n/a5 
HOMA 2.1 7.1 (2.8, 11.5) 0.001 5.6 (-0.4, 11.5) 0.07 
Abbreviations and units: Body mass index percentile, BMI %; systolic blood pressure, SBP (mm Hg); 
diastolic blood pressure, DBP (mm Hg); pulse pressure, PP (mm Hg); high-density lipoprotein cholesterol, 
HDL-C (mg/dL); non-high-density lipoprotein cholesterol, non-HDL-C [total cholesterol – HDL-C]; and 
homeostasis model assessment [insulin*glucose/405], HOMA. 
All models predicting cIMT at mean age 23 years in participants and like-aged siblings; cardiovascular risk 
factors measured at mean age 15.  
1 Model 1: adjusted for age, sex, race, tanner stage, and each cardiovascular risk factor independently. 
2 Model 2: adjusted for age, sex, race, tanner stage, and all  cardiovascular risk factors concurrently. 
3 Referents = male and white for sex and race, respectively. 
4 BMI age- and sex-adjusted percentiles based on CDC criteria used to account for pubertal development 
during adolescence. 
5 Excluded in full model due to linear dependency on other variables in the model. 
Interpretation: The change in cIMT (µm) observed from a one standard deviation unit change in 
cardiovascular risk factor z-score. 
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Table 3.4. Differences in carotid intima-media thickness (cIMT, µm) by 
cardiovascular risk factor (z-score); Prevention of High Blood Pressure in 
Children (PHBPC) study (n=444). 
  Model 11 Model 22 
  Mean ages: 23 yrs at baseline; 38 yrs at follow-up. 
 SD Coef (95% CI) p-value Coef (95% CI) p-value 
Age 1.5 5.9 (0.89, 11.1) 0.02 5.0 (-0.60, 10.6) 0.08 
Sex, female3 - -27.3 (-42.9, -
11.8) 
0.001 -26.7 (-44.4, -9.1) 0.003 
Race, black3 - 43.3 (24.8, 61.8) <0.0001 45.3 (24.8, 65.8) <0.0001 
BMI 5.8 10.9 (2.7, 19.0) 0.009 -1.2 (-11.5, 9.2) 0.83 
SBP 10.8 17.0 (8.8, 25.1) <0.0001 21.0 (10.3, 31.8) <0.0001 
DBP 9.8 3.7 (-4.5, 11.9) 0.38 -11.1 (-21.3, -
0.90) 
0.03 
PP 9.0 15.0 (7.2, 22.9) <0.0001 n/a4 n/a4 
LDL-C 27.8 6.9 (-1.1, 15.0) 0.09 n/a4 n/a4 
HDL-C 11.8 -4.2 (-12.6, 4.2) 0.33 1.1 (-8.1, 10.2) 0.82 
Non-HDL-C 32.4 8.1 (0.06, 16.2) 0.05 7.8 (-2.2, 17.8) 0.13 
Triglycerides 58.1 6.6 (-1.6, 14.9) 0.12 n/a4 n/a4 
Glucose 11.2 9.0 (0.77, 17.3) 0.03 n/a4 n/a4 
Insulin 19.8 8.5 (-0.19, 17.2) 0.06 n/a4 n/a4 
HOMA 4.4 9.4 (0.82, 18.1) 0.002 5.8 (-3.9, 15.6) 0.24 
Abbreviations and units: Body mass index, BMI (kg/m2); systolic blood pressure, SBP (mm Hg); diastolic 
blood pressure, DBP (mm Hg); pulse pressure, PP (mm Hg); high-density lipoprotein cholesterol, HDL-C 
(mg/dL); non-high-density lipoprotein cholesterol, non-HDL-C [total cholesterol – HDL-C]; and homeostasis 
model assessment [insulin*glucose/405], HOMA. 
All models predicting cIMT at mean age 38 years in participants; cardiovascular risk factors measured at 
mean age 23.  
1 Model 1: adjusted for age, sex, race, and each cardiovascular risk factor independently. 
2 Model 2: adjusted for age, sex, race, and all cardiovascular risk factors concurrently. 
3 Referents = male and white for sex and race, respectively. 
4 Excluded in full model due to linear dependency on other variables in the model. 
Interpretation: The change in cIMT (µm) observed from a one standard deviation unit change in 
cardiovascular risk factor z-score. 
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Paper 3: Ideal Cardiovascular Health and Adiposity: Implications in Youth 
 
Introduction 
To a great extent, cardiovascular disease is preventable; individuals without 
cardiovascular risk factors have low rates of cardiovascular disease in adulthood.1,99 In 
an attempt to prioritize cardiovascular health and shift towards primordial prevention, the 
American Heart Association (AHA) set 2020 Strategic Goals that included the concept of 
ideal cardiovascular health (ICH).249 ICH incorporates seven health metrics (smoking, 
body mass index [BMI], physical activity, diet, blood pressure, total cholesterol, and 
glucose), and is characterized as poor, intermediate, or ideal based on the number of 
metrics an individual meets. ICH is defined as meeting the ideal definition for all 7 
metrics. The Cardiovascular Risk in Young Finns Study reported a relationship between 
low ICH (below the median number of ‘ideal’ metrics) in childhood with cardiovascular 
disease in adulthood. A noteworthy finding was that no children in this study met all 7 
metrics for ICH.92,251 In the same cohort, individuals that changed their ICH status from 
low to high from childhood to adulthood had similar cardiometabolic health profiles as 
the participants originally classified as having high ICH as children.252  
Excess adiposity remains a serious public health threat;6,253 33% of U.S. adolescents 
are classified as having overweight or obesity.5,6 Despite a potential plateau in overall 
obesity rates, the prevalence of severe obesity in children and adolescents 2-19 years of 
age has increased from 4% in 1999-2004,254 to over 8% in 2013-14.6 Severe obesity in 
youth is associated with increased cardiometabolic risk factors,164 vascular 
dysfunction,255 increased oxidative stress,256 and risk factors for chronic disease.84 
Recent evidence suggests that cardiovascular mortality in adulthood was 3.5 times 
higher (95% CI: 2.9-4.1) for individuals classified as having obesity as adolescents.69 
The AHA estimates that 33% of adolescents do not meet the ICH metric for ideal BMI 
(i.e. were classified as having overweight or obesity).91 Given the prevalence of 
overweight and obesity in children, considerable attention has been paid to the role of 
adiposity as a precursor to the development of adult cardiovascular disease.12,13,20 
Mendelian randomization studies confirm that adiposity is a causal risk factor for 
cardiovascular risk factors and atherosclerosis in adulthood.190,191 Therefore, identifying 
children based on adiposity who are at risk for clinically evident cardiovascular disease 
later in life may be an important strategy for cardiovascular disease prevention.20,21  
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Given that pediatric cohort studies report an absence of ICH in children90,92 and 
secular trends show increases in severe obesity prevalence, the clinical utility of the ICH 
metric could be improved with a greater focus on adiposity status. Furthermore, it is 
unclear if categorizing biologically continuous risk factors for ICH estimation is the ideal 
approach.257,258 To our knowledge, no data exist on the prevalence of ICH across levels 
of adiposity in a pediatric population, nor has an adiposity specific or continuous ICH 
metric been proposed. The objectives of the current study were twofold. First, we aimed 
to improve the understanding of the distribution of ICH metrics by adiposity status. 





This cross-sectional study included 300 children and adolescents aged 8-17 years 
from the greater Minneapolis and St. Paul metropolitan area recruited from 2011-2016. 
Enrollment was stratified by adiposity: normal weight, overweight/obese, and severely 
obese. Participants were recruited from various pediatric clinics, including the University 
of Minnesota Masonic Children’s Hospital Pediatric Weight Management Clinic 
(participants with obesity or severe obesity only). Participants and parents provided 
assent and written informed consent, respectively. The study protocol was approved by 
the University of Minnesota Institutional Review Board.  
Participants were excluded if they met any of the following criteria: (i) untreated 
obstructive sleep apnea (known to impact endothelial function), (ii) genetic causes of 
obesity (i.e., Prader-Willi), (iii) previous medical history of weight loss surgery, (iv) 
current medications known to affect the endothelium (i.e., statins, ACE inhibitors, PPAR-
gamma agonists, metformin, and 3rd generation beta blockers), (v) current use of 
stimulants for Attention Deficit and Hyperactivity Disorder (e.g., methylphenidate), 
illness, hospitalization, or trauma in the previous 2 weeks, type I diabetes mellitus, 
familial hypercholesterolemia, chronic kidney disease or end-stage renal disease, 
Kawasaki disease (inflammatory disease of the vasculature), autoimmune inflammatory 
disease, or congenital heart disease. 
Ideal Cardiovascular Health Metrics 
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In 2010, the American Heart Association (AHA) established the ICH metric.249 Seven 
health metrics have been established to define cardiovascular health – categorized as 
poor, intermediate, and ideal (Table 1.1, as seen in Introduction). Ideal cardiovascular 
health is defined as meeting all seven cardiovascular health metrics and the absence of 
cardiovascular disease or cardiovascular medication use. The seven cardiovascular 
health metrics are split into 4 health behaviors (smoking status, physical activity, dietary 
patterns, and BMI) and 3 health factors (fasting total cholesterol, blood glucose, and 
blood pressure). Table 1.1 is reprinted with permission from the American Heart 
Association, and details specific definitions of poor, intermediate, and ideal 
cardiovascular health for children aged 12-19 years. 
Clinical Ideal Cardiovascular Components: BMI, Blood Pressure, Total Cholesterol, and 
Glucose 
Height was measured using a wall-mounted stadiometer; weight was measured using 
a medical-grade electronic scale. BMI was calculated and reported in kilograms per 
meter squared (kg/m2). Centers for Disease Control and Prevention definitions of sex- 
and age-based BMI percentiles (2-20 years of age) were used.259 Study BMI categories 
were defined as: normal weight: BMI < 85th percentile; overweight/obese: BMI 85th 
percentile to <1.2 times the 95th percentile, and severely obese: BMI ≥1.2 times the 95th 
percentile or BMI ≥ 35 kg/m2.84 Seated blood pressures were taken using a manual 
sphygmomanometer, using an appropriately-fitted cuff. Each participant sat quietly with 
legs uncrossed for 10 minutes prior to blood pressure measurement. Three consecutive 
blood pressure readings were taken at least 3 minutes apart. The average of the final 2 
measurements was used. Fasting blood samples (>10 hr) were collected and total 
cholesterol, low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein 
cholesterol (HDL-c), triglycerides, glucose, and insulin were measured using standard 
methods by the Fairview Diagnostics Laboratories, Fairview-University Medical Center 
(Minneapolis, MN, USA) - a Center for Disease Control and Prevention certified 
laboratory. 
Lifestyle Ideal Cardiovascular Health Components: Diet, Physical Activity, and Smoking 
Exposure 
Dietary intake was measured using the Youth/Adolescent Questionnaire (YAQ), a 
semi-quantitative food frequency questionnaire. The YAQ asks participants about dietary 
and supplement intake in the previous year.260,261 General physical activity was assessed 
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using a modified Godin Leisure-Time questionnaire262,263 that assessed: (i) intensity 
(strenuous, moderate, mild) of physical activity in the previous week during free time, (ii) 
participation in organized sports in the previous years, and (iii) leisure time physical 
activity (at least 10 times in the previous year). Smoking exposure was evaluated by 
self-report questionnaire as never, current, former, previous, or secondhand smoke 
exposure. 
Conversion from Study Instruments to Ideal Cardiovascular Health Components 
BMI categorization and total cholesterol, blood pressure, and glucose thresholds 
were consistent between the study instruments and ICH guidelines; therefore, no 
modifications were made to these variables.  Current (n=2) and former smokers (n=5) 
were categorized as meeting the definition of poor ICH, whereas never smokers (n=293) 
were classified as meeting ICH. The modified Godin Leisure-Time questionnaire 
assessed strenuous and moderate physical activity in the past week (times per week 
and minutes per session). Strenuous and moderate activity was defined as “heart beats 
rapidly” and “not exhausting,” respectively; both listed various activities that were 
relevant. For the ICH metric, we calculated minutes per day of moderate and vigorous 
physical activity using the following equation: (times per week x minutes per session)/7 
days per week. The YAQ is a 152-item food frequency questionnaire that collects a 
comprehensive assessment of food intake in the past week or month. We utilized 45 
questions that met the specified Dietary Approaches to Stop Hypertension (DASH) food 
categories for the ICH guidelines: fruits/vegetables (n=30), whole grains (n=10), fish 
(n=2), sugar sweetened beverages (n=3), and salt intake (micronutrient analysis). Nearly 
all food questions assessed frequency of intake using the following, or similar, answer 
options: 1) never/less than 1 per month, 2) 1-3 per month, 3) 1 per week, 4) 2-4 times 
per week, and 5) 5 times per week. We calculated frequency of intake by taking the 
midpoint (i.e. midpoint=2 servings per month if participant chose option #2 [1-3 per 
month]) or absolute value (i.e. serving=1 if participant chose option #3 [1 per week]) 
reported. We then calculated the total servings per unit of time for each relevant ICH 
dietary subcomponent: fruits and vegetables (≥4.5 cups per day), whole grains (≥3 
servings/day), fish (≥ 2 3.5 ounce servings/week), sugar sweetened beverages (≤36 
ounces/week), and salt (≤1500 mg/day) based on a 2000-kcal/day diet. For example, for 
fruit and vegetable consumption, each participant’s overall servings per day was a 
summary score of servings from the relevant 30 fruit/vegetable YAQ questions. This 
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process was repeated for whole grains, fish, and sugar-sweetened beverages. A 
summary salt intake was calculated using a proprietary micronutrient algorithm at the 
Harvard T.H. Chan School of Public Health Nutrition Department.  
Sociodemographics 
Age and race were determined based on self-report; race was categorized as non-
Hispanic White and Black. Socioeconomic status was approximated by self-report of free 
or reduced lunch eligibility. Sex and pubertal stage were determined by a pediatrician or 
trained nurse using classical Tanner staging.226 
Exclusions and Missing Data 
Of the 309 participants, we excluded individuals for the following reasons: 1) no 
Tanner stage performed (n=5), and 2) participant declined venipuncture, unable to 
perform a successful venipuncture, or non-fasting (n=4). Our final sample size was 300 
observations. Additional individuals would have been excluded based on missing dietary 
intake (n=154; new instrument version released mid-study, data unable to be processed 
off-site due to old versioning), physical activity (n=30), and eligibility for free or reduced 
lunch (n=183; collection began mid-study). To minimize selection bias, maximize the use 
of available information, and capture appropriate uncertainty estimates, we used multiple 
imputation by chained equations (MICE) with 25 repetitions to impute missing data for 
these individuals who would have been excluded in a complete case analysis based on 
missing data.264 Because both dietary intake and eligibility for free lunch were dependent 
on chronological time of measurement, we operated under the assumption that the 
missingness mechanism was missing at random (MAR). Results between the complete 
case analysis and non-imputed data set were similar; we opted to use the imputed data 
set based on the aforementioned strengths of MICE.  
Statistical Analysis 
Baseline characteristics of participants are described using means (SD) and 
frequency (percentages) stratified by categories of adiposity (normal weight, 
overweight/obese, and severely obese). For the first study objective, prevalence of 
overall ICH and ICH subcomponents were calculated across levels of adiposity. For the 
second study objective, a continuous ICH z-score was generated, both as an overall ICH 
score and ICH subcomponent scores. The overall ICH score was calculated based on 
the average of the individual z-scores (standardized to the sample mean and standard 
deviation) of the ICH subcomponents (BMI, physical activity, healthy diet score, total 
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cholesterol, blood pressure, and glucose). BMI was converted to age and sex-
standardized scores using Centers for Disease Control and Prevention growth 
charts.265,266 For overall blood pressure and healthy dietary consumption z-scores, an 
average of the individual z-scores (SBP and DBP percentiles for blood pressure; fruits 
and vegetables, whole grains, fish, sugar sweetened beverages and sodium intake for 
diet) was used to calculate the overall z-score. To maintain consistency in sample ICH z-
score interpretation (higher is better), all risk factors conferring cardiovascular risk were 
multiplied by -1 to flip the direction of the score (e.g., higher blood pressures have 
negative values to contribute to a lower overall ICH z-score). The z-score represents the 
number of standard deviations a measurement is from the mean, and allows comparison 
between variables measured on different scales, from different distributions. A z-score 
greater, equal to, or less than zero estimates that a particular variable is greater than, 
equal to, or less than the mean, respectively. 267,268 For our final study objective, multiple 
linear regression models were used to estimate differences in ICH z-scores by adiposity 
status after adjustment for demographics and Tanner stage (Model 1), and additional 
adjustment for reduced or free lunch eligibility (Model 2). Smoking was not included in 
our primary analysis because only 2 participants were current smokers, and 5 were 




Table 4.1 shows descriptive statistics for baseline variables presented separately by 
adiposity level (normal weight, overweight/obese, and severely obese). In general, 
participants with severe obesity were more likely to be female, non-white, have a higher 
Tanner stage of pubertal development, be eligible for reduced or free lunch, and be 
above the 90th systolic blood pressure percentile. Individuals with severe obesity also 
had higher mean insulin, LDL-c, total cholesterol, and triglyceride levels than their 
normal weight counterparts. Conversely, HDL-c was lower in participants with severe 
obesity. Of the 300 participants included in our analysis, none met the AHA definition of 
ICH (Table 4.2). When examining the prevalence of ICH components by adiposity status 
(Table 4.2), very few participants were current smokers (n=2) or had elevated glucose 
levels (n=7). Only one participant met the criteria for ideal healthy diet score. Participants 
with severe obesity were more likely to fall in the ‘poor’ ICH category for physical activity 
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level (16% vs 1%), total cholesterol (16% vs. 4%), and blood pressure (30% vs. 1%). For 
overall ICH, all participants with severe obesity were in poor cardiovascular health; most 
of the participants with overweight/obesity (81%) and normal weight (80%) were also in 
poor cardiovascular health. The total number of ICH components increased with 
healthier adiposity status; 58% of normal weight participants met the definition of 5 ICH 
components, whereas only 2% of individuals with severe obesity met the same criteria 
(Figure 4.1). 
For all results reporting continuous z-scores, a positive value indicates higher ICH 
sample z-score; a negative value represents a lower ICH sample z-score. Normal weight 
participants had a higher overall ICH sample z-score (0.80±0.9) than participants with 
overweight/obesity (-0.40±0.7) and severe obesity (-0.58±0.8) (Table 4.3). Sample z-
scores for physical activity, SBP percentile, DBP percentile, overall blood pressure 
percentile, and glucose were all in the positive range for normal weight participants, and 
negative for participants with overweight/obesity and severe obesity. The overall healthy 
diet consumption z-score followed a similar pattern, but participants with 
overweight/obesity had positive subcomponent z-score values for fruits and vegetable, 
fish, and sodium (0.03±0.9, 0.16±1.1, and 0.07±1.1, respectively). More specifically, only 
4%, 9%, and 2% of participants with normal weight, overweight/obesity, and severe 
obesity consumed the ICH recommended ≥ 2 servings of fish per week (Table 4.4). Few 
participants met the ICH sodium intake recommendations of ≤1500 mg sodium daily; 
6%, 9%, and 23% for participants with normal weight, overweight/obesity, and severe 
obesity, respectively. Ideal fruit and vegetable consumption (≥4.5 servings daily) was 
relatively consistent across all adiposity levels; ideal whole grain intake was higher in 
participants with normal weight (48%) compared with overweight/obesity (30%) and 
severe obesity (18%). Ideal levels of sugar sweetened beverages (≤36 ounces weekly) 
were most prevalent; 63%, 72% and 56% in participants with normal weight, 
overweight/obesity, and severe obesity, respectively (Table 4.4). In a multiple linear 
regression model adjusting for demographics and eligibility for free or reduced lunch, 
compared to normal weight, the ICH z-score was lower for participants with 
overweight/obesity (-1.35; 95% CI: -2.3, -1.1) and severe obesity (-1.45; 95% CI: -2.9, -





In this study, we used the AHA’s “Strategic Impact Goal Through 2020 and 
Beyond”249 ICH metric to examine the prevalence of overall ICH and subcomponents 
stratified by adiposity in youth. In addition, we generated a continuous overall ICH 
sample z-score and ICH subcomponent z-scores across levels of adiposity for an 
internal comparison. To the best of our knowledge, this is the first study to examine ICH 
metrics by adiposity status, and to create a continuous ICH z-score that captures the 
continuous nature of the data. Overall, we found that no participants achieved ICH; 13% 
and 87% of study participants were in intermediate and poor cardiovascular health, 
respectively. Importantly, 80% of normal weight, 81% of overweight/obese, and all 
participants with severe obesity were in poor cardiovascular health. After adjustment for 
demographics and eligibility for reduced or free lunch, participants with 
overweight/obesity and severe obesity had lower ICH z-scores than normal weight 
participants. 
Previous studies have found the prevalence of ICH to be low or absent in 
adolescent15,39–40, young adult,269 and adult populations.272 Our findings are consistent 
with existing literature, and extend these concerning results to a younger population 
(mean age: 12.8 years; SD 2.7). Shay and colleagues found a lack of ICH in adolescents 
aged 12-19 years; less than 50% of adolescents had ≥ 5 ICH components.91 In the 
Young Finns study, the largest pediatric cohort study to date, no participants met the 
criteria for ICH (mean age: 15.0 years; SD: 0.05).270 Because children are generally 
considered to be born with ICH,1 these collective results serve as a considerable 
reminder that ICH is being lost at younger ages, and that targeted intervention efforts to 
maintain ICH in early life may be beneficial to prevent the deterioration of ICH in 
childhood and adolescence. Given that the prevalence of ICH was absent in the current 
analysis, and that 87% of all participants were in poor cardiovascular health, the 
functionality of the ICH metric remains uncertain. Furthermore, secular trends for 
cardiovascular risk factor burden and overweight/obesity have increased or at best 
plateaued,166,167 thus raising concerns that the prevalence of ICH is unlikely to increase 
in the immediate future. We found that nearly all participants had healthy fasting blood 
glucose levels and were nonsmokers, even with a large number of participants with 
severe obesity. Furthermore, only one participant met the ideal criteria for the healthy 
diet score.  Previous studies have attempted to address this issue by dichotomizing the 
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number of ICH metrics (≤ 3 or ≥ 4 ICH metrics),270 creating summary scores for total 
number of ICH metrics present (maximum of 7),269,271 or generating a composite score 
(0, 1, or 2 assigned for poor, intermediate, and ideal cardiovascular health, respectively, 
for each of the 7 factors).91 Alternatively, it may be beneficial to consider a continuous 
ICH metric which captures the dynamic physiological state of cardiovascular health.273–
275 
A recent AHA Scientific Statement was published in late 2016, with the intention of 
being a supplemental document to the “Strategic Impact Goal Through 2020 and 
Beyond.”249 Steinberger and colleagues specifically discussed challenges and 
opportunities for cardiovascular health in children and adolescents, and addressed 
potential modifications that could improve the ICH metric.257 One of the primary 
recommendations was that future ICH tools could benefit from prioritizing continuous 
measures of risk factors. Furthermore, the ICH includes thresholds for behavioral and 
health factors that are based on percentiles calculated from population estimates. The 
authors argue that thresholds that are relevant to cardiovascular outcomes in adulthood 
would be more meaningful, but these data are generally nonexistent.257 It has previously 
been shown that continuous cluster scores in childhood can be predictive of 
cardiometabolic dysfunction in adulthood.51 In light of these considerations, our results 
include an evaluation based on comparisons using a continuous z-score in our study 
sample. After adjustment for demographics and Tanner stage, participants with 
overweight/obesity and severe obesity had lower overall ICH sample z-scores (-1.35 and 
-1.45, respectively) compared with normal weight participants; results were similar for 
ICH subcomponents. These results suggest that overweight/obesity and severe obesity 
are independent predictors of ICH, and the impact of adiposity on ICH may not be fully 
captured by weighting adiposity and other ICH metrics equally. In addition, prevalence 
estimates suggest that 80% and 81% of individuals with normal weight and 
overweight/obesity, respectively, met criteria for poor ICH (Table 4.2); ICH sample z-
scores, however, suggest that individuals with overweight/obesity have a much lower 
ICH sample z-score (-0.40±0.9) than normal weight individuals (0.80±0.9) (Table 4.3).  
Thus, prevalence estimates alone indicate that individuals with normal weight and 
overweight/obese have similar ICH, whereas ICH sample z-scores suggest that the 
overweight/obese group had lower ICH than the normal weight group. Finally, youth with 
overweight/obesity and severe obesity are rich targets for primary prevention efforts; 
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additional research is needed on the short-term impacts of lifestyle improvements on 
ICH metrics in childhood and adolescence. 
Examining the prevalence of ICH by adiposity merits independent attention for a 
variety of reasons. First, the prevalence of overweight and obesity in childhood and 
adolescence is 33% (17% and 15% are obese and overweight, respectively);166 it is 
unclear if these numbers have plateaued or continue to rise.166,167 Prevalent severe 
obesity in children and adolescents, however, has increased from 4% in 1999-2004,254 to 
over 8% in 2013-14.6 Second, adiposity in youth is a foundational risk factor subclinical 
cardiovascular disease,7,57,59,276 future obesity11, and cardiovascular disease and 
diabetes-related mortality in adulthood.69,277 Third, Mendelian randomization studies 
support a causal role for obesity in abnormal cardiovascular disease risk factors the 
development of adult atherosclerosis.190,191 Identifying children based on adiposity who 
are at risk for clinically evident cardiovascular disease later in life may be an important 
strategy for cardiovascular disease prevention.20,21 
Strengths of this study include the comparison of ICH by adiposity status in a sample 
encompassing childhood and adolescence, the rare ability to examine this relationship in 
youth with severe obesity, comprehensive cardiovascular risk factor assessment, and 
the generation of continuous ICH sample z-score for use in our study sample (overall 
and subcomponent z-scores). In the current study, prevalent overweight/obese and 
severe obesity was higher, by design, than national estimates.166,167 Nonetheless, our 
results are consistent with findings in the Young Finns study which reported that ICH 
was rare (1%), ideal fasting glucose and non-smoking status were most common, and 
ideal BMI and diet were less common.278 Lastly, these results represent the youngest 
cohort to date where ICH is absent; our results include children that are under 12 years 
of age (n=117) and therefore extend beyond the age range specified for ICH in 
childhood and adolescence (12-19 years). Importantly, higher thresholds for older 
children and adolescents may incorrectly classify younger children as being in better 
cardiovascular health, which would likely bias results towards increased ICH. 
There are a number of limitations to this study. First, certain variables that impact 
adiposity, such as genetic predisposition, were not assessed. Study exclusion criteria, 
however, attempted to identify the most common genetic conditions linked to adiposity or 
mediation known to impact adiposity status. Second, selection bias remains a possibility; 
for example, perhaps the participants with severe obesity have a different risk factor 
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profile than the target population of children and adolescents with severe obesity. 
Nonetheless, the robust sample of youth with severe obesity and concordance of 
baseline characteristics (Table 4.1) with known risk factors profiles84 give confidence to 
minimal selection bias. Third, it can be challenging to apply criteria from newly 
developed constructs (i.e. ICH) to more commonly used assessment tools for cohort 
studies or clinical trials. For example, the ICH guidelines consider dietary intake per day 
or within the previous week, whereas the YAQ food frequency questionnaire asks about 
dietary patterns in the previous week and month. Strict adherence to AHA ICH criteria in 
particular was not feasible for all criteria (i.e. dietary components or physical activity); 
reasonable approximations were made. Fifth, the use of z-scores comes with mixed 
implications.279–281 Z-scores afford the use of a continuous scale, standardize the units of 
the variables of interest, allow comparison across variables, and the ability to evaluate 
an overall ICH summary z-score as well as compare subcomponent z-scores.279,280 
Nonetheless, by transforming raw data into z-scores, the original units and clinical 
meaning are absent,279 and interpretation relies on a one standard deviation unit 
difference which can have limited clinical meaning particularly after multiple z-scores are 
combined. In addition, z-scores are known to perform poorly at extreme values of BMI in 
youth;281 we did not calculate a BMI z-score in the current analysis and instead opted to 
stratify our results by adiposity. Furthermore, z-scores that are calculated using 
observed means and standard deviations from the sample at hand, as was used here for 
several ICH components, have limited external generalizability because they are 
generated from a sample and not a target population of interest. Finally, in our primary 
analysis, we did not include smoking status in our overall z-score because there were 
very few current (n=2) and former (n=5) smokers, and smoking status did not have an 
underlying continuous scale. 
In summary, poor cardiovascular health was highly prevalent in youth, and increased 
with adiposity status. Overall ICH z-scores were lower across higher levels of adiposity; 
participants with overweight, obesity, or severe obesity had lower z-scores than their 
normal weight counterparts. Youth remain a rich target for primary prevention efforts 
targeting behavioral change.  Modifying the ICH to a continuous metric could further 
enhance its ability to stratify cardiovascular risk; data that capture a representative 
sample in addition to cardiovascular outcomes are critical to assessing the utility of a 
generalizable continuous metric. Identifying characteristics of children and adolescents 
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that have poor or intermediate ICH based on adiposity status has potential implications 
for interventions to prevent future cardiovascular disease in youth with obesity. 
Implementing more aggressive primary prevention intervention efforts in youth with 




Table 1.1.  Definitions of poor, intermediate, and ideal cardiovascular health 
according to AHA 2020 goals: health behaviors and risk factors for children 12-19 
years of age. 
Metric Poor Intermediate Ideal 
Smoking status Tried > 30 d ago … Never tried; never smoked whole cigarette 
BMI >95th percentile 85th- 95th percentile <85th percentile 
Physical activity 
level None 
>0 and <60 min moderate 
or vigorous activity every 
day 
≥60 min moderate or 
vigorous activity every 
day 
Healthy Diet Score* 0-1 components 2-3 components 4-5 components 
Total Cholesterol ≥200 mg/dL ≥170 - <200 mg/dL <170 mg/dL 
Blood Pressure >95th percentile 90-95th percentile <90th percentile 
Fasting Blood 
Glucose ≥126 mg/dL 100 - 125 mg/dL <100 mg/dL 
BMI indicates body mass index. 
* The Healthy Diet Score is based on adherence to the following dietary recommendations: fruits and 
vegetables, ≥4.5 cups per day; fish, 2 or more 3.5-oz servings per week; sodium, <1500 mg/d; sugar-
sweetened beverages, ≤450 kcal (36 oz) per week; and whole grains, ≥3 servings a day scaled to a 2000-























Table 4.1. Baseline characteristics by adiposity status (n=300). 
 Adiposity Status 
 NW OW/OB SO 
N 113 87 100 
BMI, kg/m2 (SD) 18.4 (2.4) 26.5 (3.5) 35.9 (6.1) 
BMI, percentile (SD)1 73.6 (6.7) 106.0 (10.0) 140.1 (16.8) 
Total tissue fat, N (%) 25.2 (6.1) 39.5 (7.2) 48.1 (4.9) 
Visceral fat mass, g (SD) 74 (54.0) 412.5 (275) 1097 (585) 
Demographics    
Age, years (SD) 12.5 (2.5) 12.5 (2.5) 13.1 (2.7) 
Male, N (%) 68 (58) 43 (48) 38 (38)  
Race, N (%)    
White 109 (93) 74 (83) 77 (76) 
Other 8 (7) 15 (17) 24 (24) 
Tanner stage, N (%)    
1 45 (39) 23 (27) 16 (16) 
2 20 (17) 18 (21) 26 (26) 
3 17 (15) 18 (21) 18 (18) 
4 22 (19) 15 (17) 22 (22) 
5 11 (10) 12 (14) 17 (17) 
Free or reduced lunch 
eligibility, N (%) 
17 (15) 16 (18) 34 (34) 
Clinical variables    
Weight, kg (SD) 44.3 (13.1) 65.9 (16.8) 93.8 (26.5) 
Height, cm (SD) 153.2 (15.1) 156.3 (13.7) 159.8 (12.5) 
WC, cm (SD) 63.2 (6.9) 80.5 (9.5) 100.0 (14.6) 
SBP, mm Hg (SD) 107 (11) 116 (11) 124 (12) 
SBP ≥ 90th percentile, N (%) 4 (3) 18 (20) 51 (50) 
DBP, mm Hg (SD) 54 (7) 58 (9) 61 (8) 
DBP ≥ 90th percentile, N (%) 1 (1) 3 (3) 3 (3) 
Insulin, mU/L (SD) 4 (3) 10 (6) 17 (11) 
Glucose, mg/dl (SD) 78 (9) 81 (9) 80 (8) 
LDL-c, mg/dl (SD) 81 (24) 95 (24) 97 (28) 
HDL-c, mg/dl (SD) 57 (12) 47 (12) 41 (9) 
Total cholesterol, mg/dl (SD) 153 (27) 165 (27) 164 (31) 
TG, mg/dl (SD) 71 (27) 113 (56) 133 (50) 
Percentages may not add up to 100% based on rounded estimates. 
Abbreviations: Normal weight, NW; overweight, OW; obese, OB; severely obese, SO; waist circumference, 
WC; systolic blood pressure, SBP; diastolic blood pressure, DBP; low-density lipoprotein cholesterol, LDL-c; 
high-density lipoprotein cholesterol, HDL-c; triglycerides, TG. 




Table 4.2. Ideal cardiovascular health (ICH) components by adiposity status 
(n=300). 
  Adiposity Status 
 Overall, N % NW OW/OB SO 
N 300 113 87 100 
Overall ICH prevalence, N %     
Ideal 0 (0) 0 (0) 0 (0) 0 (0) 
Intermediate  40 (13) 23 (20) 17 (19) 0 (0) 
Poor 260 (87) 90 (80) 70 (81) 100 (100) 
ICH Components  
Body mass index percentile, N %     
Ideal 113 (38) 113 (100) 0 (0) 0 (0) 
Intermediate  20 (7) 0 (0) 20 (23) 0 (0) 
Poor 167 (56) 0 (0) 67 (77) 100 (100) 
Smoking Status, N %     
Ideal 298 (99) 112 (99) 87 (100) 99 (99) 
Intermediate  - - - - 
Poor 2 (1) 1 (1) 0 (0) 1 (1) 
Physical activity2, N %     
Ideal 57 (19) 28 (25) 17 (19) 12 (12) 
Intermediate  222 (74) 84 (74) 66 (76) 72 (72) 
Poor 21 (7) 1 (1) 4 (5) 16 (16) 
Healthy diet score, N %     
Ideal 1 (1) 0 (0) 1 (1) 0 (0) 
Intermediate  62 (21) 25 (22) 23 (26) 14 (14) 
Poor 237 (79) 88 (78) 63 (72) 86 (86) 
Total cholesterol, N %     
Ideal 194 (65) 84 (74) 51 (59) 59 (59) 
Intermediate  78 (26) 25 (22) 28 (32) 25 (25) 
Poor 28 (9) 4 (4) 8 (9) 16 (16) 
Blood pressure, N %     
Ideal 202 (67) 104 (92) 60 (69) 38 (38) 
Intermediate  59 (20) 8 (7) 19 (22) 32 (32) 
Poor 39 (13) 1 (1) 8 (9) 30 (30) 
Glucose, N %     
Ideal 293 (98) 110 (97) 86 (99) 97 (97) 
Intermediate  2 (1) 1 (1) 0 (0) 1 (1) 
Poor 5 (2) 2 (2) 1 (1) 2 (2) 
Percentages may not add up to 100% based on rounded estimates. 
Abbreviations: normal weight, NW; overweight, OW; obese, OB; severely obese, SO.  
1 Ideal cardiovascular health defined by Lloyd-Jones et al. as meeting American Heart Association 
definitions of ideal on four health behavior metrics and three health factor metrics concurrently.  Intermediate 
cardiovascular health defined as meeting at least one intermediate metric and no poor metrics.  Poor 
cardiovascular health defined as having at least one poor metric. 
2 Moderate and/or vigorous physical activity. 
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Figure 4.1. Prevalence of number of Ideal Cardiovascular (ICH) subcomponents1 
by adiposity status (n=300). 
 






1Those in the OW/OB and SO categories unable to attain 7 ICH components based on adiposity status. 




Table 4.3. Mean z-score of Ideal Cardiovascular Health components by adiposity 
status (n=300). 
  Adiposity Status 
 SD1 NW OW/OB SO 
N 300 113 87 100 
ICH components2  ICH z-score  
(SD) 
ICH z-score  
(SD) 
ICH z-score  
(SD) 
Physical activity, (SD) 31 0.32 (1.0) -0.08 (1.0) -0.32 (0.9) 
Healthy diet consumption, (SD)     
Fruits/vegetables 1.8 0.04 (0.9) 0.03 (0.9) -0.07 (1.1) 
Fish 0.7 0.03 (0.9) 0.16 (1.1) -0.23 (0.9) 
Whole grains 1.5 0.42 (1.0) -0.15 (0.9) -0.29 (0.9) 
Sugar sweetened beverages 54.7 0.07 (1.0) -0.25 (1.0) -0.24 (1.0) 
Sodium 819 0.13 (0.9) 0.07 (1.1) -0.25 (1.1) 
Overall diet summary score3 - 0.11 0.9) 0.09 (0.9) -0.24 (1.1) 
Total cholesterol, (SD) 29 0.22 (1.0) -0.16 (0.9) -0.14 (1.1) 
Blood pressure %, (SD)     
SBP percentile 29 0.59 (0.9) -0.06 (0.9) -0.61 (0.8) 
DBP percentile 22 0.29 (0.9) -0.01 (1.0) -0.30 (1.0) 
Overall BP percentile summary score3 - 0.51 (0.9) -0.04 (0.9) -0.52 (0.9) 
Glucose, (SD) 9 0.20 (1.0) -0.16 (1.0) -0.08 (0.9) 
Overall ICH summary score, (SD)3 - 0.80 (0.9) -0.40 (0.7) -0.58 (0.8) 
Interpretation: A z-score ≤ 0 indicates a variable is less than the mean (lower ICH); a z-score ≥ 0 indicates a 
variable is great than the mean (higher ICH). 
Abbreviations: normal weight, NW; overweight, OW; obese, OB; severely obese, SO; standard deviation, 
SD; systolic blood pressure, SBP; diastolic blood pressure, DBP; blood pressure, BP; ideal cardiovascular 
health, ICH. 
1Units for standard deviations: physical activity (minutes); diet: fruits/vegetables and whole grains 
(servings/day), fish (servings/week), sugar sweetened beverages (ounces/week), sodium (mg/day); total 
cholesterol and glucose (mg/dL); blood pressure (percentile).  SD for absolute SBP and DBP was 13 mm Hg 
and 9 mm Hg, respectively.  
2Did not include smoking status; only 2 participants were current smokers and dichotomized nature of 
smoking variable made z-score transformation less straight forward. 
3 Overall summary z-scores were calculated based on the average of the individual subcomponents: diet 
(fruits/vegetables, fish, whole grains, sugar sweetened beverages, and sodium); blood pressure percentile 
(systolic and diastolic blood pressure percentiles) overall ICH (physical activity, diet, SBP, total cholesterol, 
and blood glucose). See Methods section for a more detailed description. 
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Table 4.4. Mean Ideal Cardiovascular Health (ICH) diet subcomponent 
consumption and prevalence of ideal consumption by adiposity status (n=300). 
  Adiposity Status 
 Overall NW OW/OB SO 
N 300 113 87 100 
Ideal healthy diet subcomponents     
Fruits & vegetables, servings per day 
(SD) 
3.6 (1.8) 3.6 (1.7) 3.6 (1.7) 3.4 (2.2) 
Whole grains, servings per day (SD) 2.7 (1.5) 3.3 (1.5) 2.5 (1.4) 2.2 (1.3) 
Fish, servings per day (SD)  0.71 (0.70) 0.73 (0.61) 0.82 (0.87) 0.55 (0.53) 
SSB, ounces per week (SD) 43 (55) 47 (57) 29 (27) 56 (73) 
Sodium, mg per day (SD) 2353 (819) 2466 (698) 2419 (874) 2152 (856) 
Ideal healthy diet consumption1  
Fruits & vegetables, N (%) 84 (28) 28 (25) 24 (28) 30 (30) 
Whole grains, N (%) 96 (32) 54 (48) 26 (30) 18 (18) 
Fish, N (%) 18 (6) 5 (4) 8 (9) 2 (2) 
SSB, N (%) 192 (64) 71 (63) 63 (72) 56 (56) 
Sodium, N (%) 36 (12) 7 (6) 8 (9) 23 (23) 
Abbreviations: Overweight, OW; obese, OB; standard deviation, SD; sugar sweetened beverages, SSB. 
1 Based on AHA guidelines, consistent with Dietary Approaches to Stop Hypertension (DASH) dietary 
pattern: to consume ≥4.5 cups/day of fruits and vegetables, ≥2 servings/week of fish, and ≥3 servings/d of 
whole grains and no more than 36 oz/week of sugar-sweetened beverages and 1500 mg/day of sodium. 
 
 
Table 4.5. Differences in overall Ideal Cardiovascular Health z-score by adiposity 
status (n=300). 
 Model 11 Model 22 
 N=300 N= 300 
 ICH z-score 
difference  (95% CI) 
p-value ICH z-score 
difference (95% CI) 
p-value 
Age (per year) -0.05 (-0.13, 0.03) 0.232 -0.04 (-0.13, 0.02) 0.346 
Male (vs. Female) 0.20 (-0.09, 0.50) 0.181 0.14 (-0.14, 0.34) 0.397 
Race: Black (vs. White) -0.01 (-0.15, 0.12) 0.849 -0.08 (-0.10, 0.33) 0.761 
Tanner stage 0.02 (-0.13, 0.18) 0.786 0.03 (-0.13, 0.15) 0.944 
Adiposity status3     
Normal Weight Referent -- Referent --  
Overweight/obesity -1.24 (-1.57, -0.91) <0.0001 -1.35 (-2.3, -1.1) <0.0001 
Severe obesity -1.41 (-1.80, -1.01) <0.0001 -1.45 (-2.9, -0.92) <0.0001 
Free or reduced lunch eligibility - - -0.10 (-0.92, 0.73) 0.812 
All linear regression models examining overall cross-setional ICH z-score at mean age 12.8±2.7 years.  
1 Model 1: adjusted for age, sex, race, tanner stage, and adiposity status. 
2 Model 2: Model 1 + reduced free lunch eligibility. 
3 BMI age- and sex-adjusted percentiles based on CDC criteria used to account for pubertal development 
during adolescence.  
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Conclusion 
Excess adiposity remains a serious public health threat; 33% of U.S. adolescents 
are classified as having overweight or obesity. Adolescent obesity is associated with a 
3.5 times higher lifetime risk of cardiovascular disease (CVD) mortality, thus subclinical 
cardiovascular (CV) phenotypes such as carotid intima-media thickness (cIMT) have 
become widely accepted as relevant to earlier stages of CV disease in youth. This 
dissertation used two longitudinal pediatric cohort studies and one pediatric clinical trial 
to examine the implications of excess adiposity in youth. 
In the first manuscript, we developed a risk prediction model that predicted cIMT in 
middle adulthood using relevant CV risk factors in adolescence. Although longitudinal 
associations were observed between most CVD risk factors in adolescence and 
increased cIMT in middle adulthood, our risk prediction model poorly predicted cIMT in 
middle adulthood based on discrimination and calibration metrics. Future efforts to 
develop a methodologically robust risk prediction model utilizing risk factors in 
adolescence to predict subclinical atherosclerosis in middle adulthood could benefit 
children and adolescents at risk for developing subclinical atherosclerosis in a number of 
ways. First, individuals with high-risk scores could be differentiated from those with low-
risk scores without having to measure vascular pathology. Consequently, treatment 
optimization could be tailored for high-risk individuals. Second, risk factor treatment 
(behavioral or pharmacological) could be monitored over time, thereby allowing for a 
more personalized approach to prevention and management of atherosclerosis.   
In the second manuscript, we used longitudinal data from two bi-racial cohort 
studies to examine the association between CV risk factors and common cIMT in two 
distinct periods in life: (i) between adolescence and young adulthood (mid 20’s), and (ii) 
between young adulthood (mid 20’s) and early middle age (mid 30’s). Higher body mass 
index was associated with an increased cIMT in the younger cohort. In the older cohort, 
no association was present between BMI and cIMT; higher SBP was associated with 
increased cIMT. These results suggest that youth is a critical period for detection and 
intervention to preserve future cardiovascular health. Initiation of preventive strategies in 
adolescence and young adulthood, particularly in regard to adiposity in adolescence and 
blood pressure in the mid 20’s, may reduce future subclinical atherosclerosis 
development.  
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The American Heart Association set 2020 Strategic Impact Goals that defined CV risk 
factors to be included in the concept of ideal cardiovascular health (ICH). In the final 
manuscript, we examined the prevalence of ICH among differing levels of adiposity in 
youth, including severe obesity. In addition, we generated a continuous ICH sample z-
score, and examined the distribution of the ICH sample z-score stratified by adiposity 
groups in youth. After adjustment for demographics, children with overweight/obesity 
and severe obesity had lower ICH sample z-scores than those with normal weight. 
Pediatricians face numerous challenges when addressing weight management in a 
clinical setting. One of these hurdles involves addressing behavioral changes for families 
struggling with weight issues. On the other end of the spectrum, clinicians with expertise 
in weight management have limited options for clinical management of severe obesity 
and associated comorbidities.  Although our ICH sample z-score is only applicable to our 
study population, conceptually it provides a platform to consider the future development 
of a generalizable ICH z-score created from a representative data source.  Clinicians 
and researchers alike could potentially use a generalizable ICH z-score to: (i) provide a 
more comprehensive indicator of cardiovascular health than many metrics currently 
available (e.g. BMI), and (ii) provide a metric that may be more amenable to detect 
cardiovascular health improvement or deterioration as a result of behavioral change. 
Taken together, these three projects provide insight into the relationship between 
excess adiposity and subclinical CV disease and CV health in youth. In addition, this 
dissertation considers metrics that have the potential to address excess adiposity 
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